FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Meletios Dimopoulos

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Giannis Mountzios; Dimitrios Pectasides; Eirini Pectasides; Aspasia Soultati; Meletios A Dimopoulos; Christos A Papadimitriou
Developments in the systemic treatment of metastatic cervical cancer.
Theodora Psaltopoulou; Theodoros N Sergentanis; Evangelos Terpos; Prodromos Kanavidis; Nick Kanellias; Meletios A Dimopoulos
Tobacco smoking and risk of multiple myeloma: a meta-analysis of 40 observational studies.
Meletios A Dimopoulos; Roman Hájek; Martin Kropff; Philip Lewis; Jay Mei; Annabel Nixon; Maria T Petrucci; Jingshan Zhang; Michel Delforge; Antonio Palumbo
Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Meletios Dimopoulos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Giannis Mountzios; Dimitrios Pectasides; Eirini Pectasides; Aspasia Soultati; Meletios A Dimopoulos; Christos A Papadimitriou
Developments in the systemic treatment of metastatic cervical cancer.
Cancer treatment reviews 2013;39(5):430-43.
2013: Theodora Psaltopoulou; Theodoros N Sergentanis; Evangelos Terpos; Prodromos Kanavidis; Nick Kanellias; Meletios A Dimopoulos
Tobacco smoking and risk of multiple myeloma: a meta-analysis of 40 observational studies.
International journal of cancer. Journal international du cancer 2013;132(10):2413-31.
2013: Meletios A Dimopoulos; Roman Hájek; Martin Kropff; Philip Lewis; Jay Mei; Annabel Nixon; Maria T Petrucci; Jingshan Zhang; Michel Delforge; Antonio Palumbo
Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.
Haematologica 2013;98(5):784-8.
2013: Ashutosh D Wechalekar; Lisa Rannigan; Stefan O Schonland; Meletios A Dimopoulos; Darren Foard; Andrea Foli; Julian D Gillmore; Philip N Hawkins; Ute Hegenbart; Efstathios Kastritis; Thirusha Lane; Giampaolo Merlini; Paolo Milani; Giovanni Palladini
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.
Blood 2013;121(17):3420-7.
2013: Evangelos Terpos; G David Roodman; Meletios A Dimopoulos
Optimal use of bisphosphonates in patients with multiple myeloma.
Blood 2013;121(17):3325-8.
2013: Meletios A Dimopoulos; Evangelos Terpos; Efstathios Kastritis
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia.
Clinical lymphoma, myeloma & leukemia 2013;13(2):235-7.
2013: Efstathios Kastritis; M Migkou; Lia A Moulopoulos; Maria Roussou; Maria Spyropoulou-Vlachou; Anna Tasidou; Evangelos Terpos; E Eleftherakis-Papaiakovou; M Gavriatopoulou; M Gkotzamanidou; N Kanellias; Meletios A Dimopoulos
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease.
Leukemia 2013;27(4):947-53.
2013: Aristotelis Bamias; M Chrisophos; C Constantinidis; Urania Dafni; C Deliveliotis; Gerasimos Aravantinos; A Eleftheraki; George Fountzilas; C Hatzimouratidis; A Karadimou; V Koutoulidis; Dimitrios Pectasides; A Psyrri; Epaminondas Samantas; K Stravodimos; Eleni Timotheadou; Marinos L Tsiatas; A Visvikis; Ioannis Xanthakis; Meletios A Dimopoulos
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):1011-7.
2013: Maria T Petrucci; Adriana Teixeira; Nathalie Allietta; Ralf Angermund; Igor W Blau; Esther Broer; Paolo Corradini; Meletios A Dimopoulos; Johannes Drach; Pilar Giraldo; Vivien Mitchell; Joan Bladé
A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma.
British journal of haematology 2013;160(5):649-59.
2013: Jesús F San Miguel; Rudolf Schlag; Ofer Shpilberg; Ivan Spicka; Helgi van de Velde; Olga S Samoilova; Kudrat M Abdulkadyrov; Kenneth C Anderson; Andrew Cakana; Michel Delforge; William Deraedt; Meletios A Dimopoulos; Anna Dmoszynska; Dixie-Lee Esseltine; Bin Jiang; Nuriet K Khuageva; Martin Kropff; Kevin Liu; Maria-Victoria Mateos; Antonio Palumbo; Maria Teresa Petrucci; Paul G Richardson
Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(4):448-55.
2013: Meletios A Dimopoulos; M Gkotzamanidou; Charis Matsouka; D Mparmparoussi; N Nikitas; Erasmia Psimenou; Maria Roussou; Maria Spyropoulou-Vlachou; Evangelos Terpos; Efstathios Kastritis
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.
Leukemia 2013;27(2):423-9.
2013: Evangelos Terpos; Dimitrios Christoulas; Nikolaos Kanellias; Efstathios Kastritis; Meletios A Dimopoulos
Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma.
OncoTargets and therapy 2013;6():531-8.
2013: George Fountzilas; Helen Gogas; Konstantine T Kalogeras; Charisios Karanikiotis; George Klouvas; Triantafyllia Koletsa; Ioannis Kostopoulos; Vassiliki Kotoula; Angelos Koutras; Helena Linardou; Christos Papadimitriou; Nicholas Pavlidis; Dimitrios Pectasides; Nikolaos Pisanidis; Epaminondas Samantas; Ioanna Sfakianaki; Despina Televantou; Eleni Timotheadou; Eleftheria Tsolaki; Ioannis Xanthakis; Anna Batistatou; Mattheos Bobos; Urania Dafni; Meletios A Dimopoulos
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
BMC cancer 2013;13():163.
2013: Alexandra V Stavropoulou; Eleni Timotheadou; Olga Triantafyllidou; Marianthi Tsitlaidou; Gerassimos E Voutsinas; Drakoulis Yannoukakos; Thomas Makatsoris; Christos Papadimitriou; Dimitrios Pectasides; George Pentheroudakis; Maroulio Pertesi; Gerasimos Aravantinos; Aristotelis Bamias; Christos Christodoulou; Meletios A Dimopoulos; Florentia Fostira; George Fountzilas; Vassilis Karydakis; George Klouvas; Irene Konstantopoulou
Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.
PloS one 2013;8(3):e58182.
2012: Giovanni Palladini; Stefan Schönland; Ashutosh Wechalekar; Raymond Comenzo; Meletios A Dimopoulos; Angela Dispenzieri; Morie A Gertz; Philip N Hawkins; Ute Hegenbart; Arnaud Jaccard; Efstathios Kastritis; Catherine Klersy; Shaji Kumar; Giampaolo Merlini
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(36):4541-9.
2012: Evangelos Terpos; Efstathios Kastritis; Meletios A Dimopoulos
Prevention and treatment of myeloma bone disease.
Current hematologic malignancy reports 2012;7(4):249-57.
2012: Meletios A Dimopoulos; Hartmut Goldschmidt; Tomer Mark; Adrian Alegre; Evangelos Terpos; Ruben Niesvizky
Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment.
Cancer treatment reviews 2012;38(8):1012-9.
2012: N G Gavalas; Dimitrios Haidopoulos; K Ioannou; E Politi; Alexandros Rodolakis; Evangelos Terpos; Nikolaos Thomakos; Marinos L Tsiatas; Ourania E Tsitsilonis; George Vlahos; A C Ziogas; A Antsaklis; Meletios A Dimopoulos; Aristotelis Bamias
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2.
British journal of cancer 2012;107(11):1869-75.
2012: Evangelos Terpos; Efstathios Kastritis; Michel Rybojad; Bouchra Asli; Djaouida Bengoufa; Jean-Claude Brouet; Dimitrios Christoulas; Meletios A Dimopoulos; Jean-Paul Fermand
Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome.
Haematologica 2012;97(11):1699-703.
2012: Efstathios Kastritis; Meletios A Dimopoulos
VWF, WM, and angiogenesis: is there a link?
Blood 2012;120(16):3163-4.
2012: Evangelos Terpos; D Christoulas; E Eleutherakis-Papaiakovou; M Gkotzamanidou; N Kanellias; Efstathios Kastritis; Athanasios Papatheodorou; Meletios A Dimopoulos
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2681-6.
2012: Evangelos Terpos; Konstantinos Zervas; Cornelia Bratengeier; Dimitrios Christoulas; Sosana Delimpasi; Maria Gkotzamanidou; Efstathios Kastritis; Eirini Katodritou; John Meletis; Eurydiki Michalis; Anastasia Pouli; Meletios A Dimopoulos
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy.
International journal of cancer. Journal international du cancer 2012;131(6):1466-71.
2012: Esftathios Kastritis; Meletios A Dimopoulos; Joan Bladé
Evolving chemotherapy options for the treatment of myeloma kidney: a 40-year perspective.
Advances in chronic kidney disease 2012;19(5):312-23.
2012: Lia A Moulopoulos; Maria Roussou; Dimitrios Christoulas; Meletios A Dimopoulos; Evangelos Eleutherakis-Papaiakovou; Maria Gavriatopoulou; Dimitra Gika; Maria Gkotzamanidou; Efstathios Kastritis; Andreas Koureas; Vassilios Koutoulidis; Magdalini Migkou; Evangelos Terpos
Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
American journal of hematology 2012;87(9):861-4.
2012: Maria Gkotzamanidou; Efstathios Kastritis; Lia A Moulopoulos; Dimitrios Christoulas; Meletios A Dimopoulos; Evangelos Terpos
Sclerostin: a possible target for the management of cancer-induced bone disease.
Expert opinion on therapeutic targets 2012;16(8):761-9.
2012: Georgia Levidou; Afroditi Nonni; Irene Papaspirou; Efstratios Patsouris; Maria Sotiropoulou; Kiriaki Ventouri; Aristotle Bamias; Meletios A Dimopoulos; Hariklia Gakiopoulou; Penelope Korkolopoulou
Replication protein A in nonearly ovarian adenocarcinomas: correlation with MCM-2, MCM-5, Ki-67 index and prognostic significance.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2012;31(4):319-27.
2012: Anna Tasidou; Evangelos Terpos; Dimitra Anagnostou; Evangelos Eleutherakis-Papaiakovou; Maria Gavriatopoulou; Maria Gkotzamanidou; Efstathios Kastritis; Magdalini Migkou; Nikitas Nikitas; Maria Roussou; Meletios A Dimopoulos
Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents.
American journal of hematology 2012;87(7):734-6.
2012: Meletios A Dimopoulos; Dimitra Gika; Evdoxia Hatjiharissi; Eleftheria C Hatzimichael; Zafiris Kartasis; Efstathios Kastritis; Eirini Katodritou; Marie-Christine Kyrtsonis; Michalis Michael; Evridiki Michalis; Agapi Parcharidou; Panayiotis Repousis; Ekaterini Stefanoudaki; Argyris Symeonidis; Evangelos Terpos; Costas Tsatalas; Maria Tsirogianni; Konstantinos Zervas; Sossana Delimpasi
Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.
European journal of haematology 2012;89(1):10-5.
2012: Aristotelis Bamias; A Antsaklis; Dimitrios Haidopoulos; K Kakoyianni; E Kostouros; A Rodolakis; K Sakellariou; Maria Sotiropoulou; Nikolaos Thomakos; P Trachana; George Vlahos; Flora Zagouri; Meletios A Dimopoulos
Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor.
European journal of cancer (Oxford, England : 1990) 2012;48(10):1476-83.
2012: Efstathios Kastritis; Smaragda Marinaki; Evridiki Michalis; Nikitas Nikitas; Constantinos Pamboukas; Maria Roussou; Evangelos Terpos; Theofanis Apostolou; Ioannis Boletis; Sossana Delimpasi; Maria Gavriatopoulou; Georgios Gkortzolidis; Meletios A Dimopoulos
A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis.
Blood 2012;119(23):5384-90.
2012: Antonio Palumbo; Maria Teresa Petrucci; Torben Plesner; Joergen Radke; Ivan Spicka; Katja Weisel; Wiesław Wiktor-Jędrzejczak; Zhinuan Yu; Mamia Zodelava; Meral Beksac; Dina Ben Yehuda; Joan Bladé; Nicola Cascavilla; John Catalano; Michele Cavo; Alessandro Corso; Michel Delforge; Meletios A Dimopoulos; Heinz Gisslinger; Roman Hajek; Lindsay Herbein; Genadi Iosava; Christian Jacques; Janusz Kloczko; Martin Kropff; Christian Langer; Jay Mei
Continuous lenalidomide treatment for newly diagnosed multiple myeloma.
The New England journal of medicine 2012;366(19):1759-69.
2012: Asher A Chanan-Khan; Sundar Jagannath; Heinz Ludwig; Jesús F San Miguel; Meletios A Dimopoulos
Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(8):2145-63.
2012: Helen Gogas; Haralabos P Kalofonos; Charisios Karanikiotis; Maria Karina; Paris Kosmidis; Christos Markopoulos; Christos Papadimitriou; Pavlos Papakostas; Dimitrios Pectasides; Epaminondas Samantas; George P Stathopoulos; Eleni Timotheadou; Dimitrios Bafaloukos; Anna Batistatou; Mattheos Bobos; Evangelos Briasoulis; Christos Christodoulou; Urania Dafni; Meletios A Dimopoulos; Anastasia G Eleftheraki; George Fountzilas
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
Breast cancer research and treatment 2012;132(2):609-19.
2012: Meletios A Dimopoulos; Nancy Brandenburg; Ruben Niesvizky; Paul G Richardson; Donna M Weber; Zhinuan Yu; Gareth J Morgan
A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide.
Blood 2012;119(12):2764-7.
2012: Meletios A Dimopoulos; Dimitra Gika; Zafiris Kartasis; Efstathios Kastritis; Kostas Konstantopoulos; M Michael; Evridiki Michalis; Agapi Parcharidou; Anastasia Pouli; Maria Roussou; Evangelos Terpos; Costas Tsatalas; Konstantinos Zervas; Athanasios Zomas; S Delimpasi
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(3):722-9.
2012: Ourania Nicolatou-Galitis; Dimitrios Pectasides; Amanda Psyrri; Judith E Raber-Durlacher; Aristotle Bamias; George Dimitriadis; Theofanis Economopoulos; Magdalini Migkou; Meletios A Dimopoulos
Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications.
Oral surgery, oral medicine, oral pathology and oral radiology 2012;113(2):234-8.
2012: Efstathios Kastritis; Meletios A Dimopoulos
When a little aspirin may be enough.
Blood 2012;119(4):905-6.
2012: George Fountzilas; Helen Gogas; Konstantine T Kalogeras; Triantafyllia Koletsa; Vassiliki Kotoula; Angelos Koutras; Vassiliki Malamou-Mitsi; Spyros Miliaras; Savvas Papadopoulos; Dimitrios Pectasides; Dimosthenis V Skarlos; Maria Sotiropoulou; Despina Televantou; Helen Trihia; Dimitrios Bafaloukos; Anna Batistatou; Mattheos Bobos; Sofia Chrisafi; Urania Dafni; Theodoros Filippidis; Meletios A Dimopoulos
Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.
PloS one 2012;7(6):e37946.
2012: Theodoros P Vassilakopoulos; Effimia Vrakidou; Alexandra Zorbala; Photis Beris; Nikos Constantinou; John Dervenoulas; Evangelia M Dimitriadou; Meletios A Dimopoulos; Maria N Dimopoulou; Zacharoula Galani; Christina Kalpadakis; Andreas Katsigiannis; Styliani Kokoris; Marie-Christine Kyrtsonis; John Meletis; Panayiotis Panayiotidis; Gerassimos A Pangalis; Sotirios G Papageorgiou; Christos Poziopoulos; Panagiotis Repoussis; Paraskevi Roussou; Sotirios Sachanas; Marina P Siakantaris; Evangelos Terpos; Maria K Angelopoulou
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.
The oncologist 2012;17(2):239-49.
2011: Evangelos Eleftherakis-Papapiakovou; Maria Gkotzamanidou; Irini Grapsa; Efstathios Kastritis; Nikitas Nikitas; Erasmia Psimenou; Maria Roussou; Evangelos Terpos; Meletios A Dimopoulos
Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens.
Leukemia & lymphoma 2011;52(12):2299-303.
2011: Magdalini Migkou; Evangelos Terpos; Meletios A Dimopoulos; Maria Gkotzamanidou; Efstathios Kastritis
Response to bortezomib of a patient with scleromyxedema refractory to other therapies.
Leukemia research 2011;35(11):e209-11.
2011: Antonio Palumbo; Laura Rosiñol; Jesus F San Miguel; Orhan Sezer; Andrew Spencer; Evangelos Terpos; Sonja Zweegman; Meral Beksac; Joan Bladé; Mario Boccadoro; Sara Bringhen; Michele Cavo; Faith Davies; Meletios A Dimopoulos; Christoph Driessen; Hermann Einsele; Peter Gimsing; Martin Gramatzki; Roman Hàjek; Hans E Johnsen; Fernando Leal Da Costa; Henk Lokhorst; Heinz Ludwig; Maria V Mateos; Gareth Morgan; Pieter Sonneveld
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).
Blood 2011;118(17):4519-29.
2011: Maria Gkotzamanidou; Efstathios Kastritis; Charis Matsouka; Despina Mparmparousi; Nikitas Nikitas; Evangelos Terpos; Maria Roussou Magdalini Migkou Maria Gavriatopoulou; Dimitra Gika; Meletios A Dimopoulos
Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma.
Clinical lymphoma, myeloma & leukemia 2011;11(5):409-13.
2011: Aristotelis Bamias; Aris Antsaklis; Dimitrios Haidopoulos; A Karadimou; Alexandros Rodolakis; Maria Sotiropoulou; N Soupos; Nikolaos Thomakos; F Zagouri; Meletios A Dimopoulos
Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.
Gynecologic oncology 2011;123(1):37-42.
2011: Meletios A Dimopoulos; M Hussein; A S Swern; D Weber
Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myeloma.
Leukemia 2011;25(10):1620-6.
2011: Esperanza Such; Evangelos Terpos; Amparo Avaria; José V Bagán; José Cervera; Lourdes Cordón; Meletios A Dimopoulos; Inés Gómez; Mariam Ibañez; Irene Luna; María Margaix; Mónica Roig; Miguel A Sanz; Javier de la Rubia
CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Haematologica 2011;96(10):1557-9.
2011: Niki Kontou; Demosthenes B Panagiotakos; Theodora Psaltopoulou; Meletios A Dimopoulos; Athena Linos
The mediterranean diet in cancer prevention: a review.
Journal of medicinal food 2011;14(10):1065-78.
2011: Magdalini Migkou; Despina Mparmparoussi; Nikitas Nikitas; Maria Roussou; Evangelos Terpos; Maria Gavriatopoulou; Dimitra Gika; Maria Gkotzamanidou; Efstathios Kastritis; Charis Matsouka; Meletios A Dimopoulos
Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy.
European journal of haematology 2011;87(4):323-9.
2011: Meletios A Dimopoulos; Evangelos Terpos
Advances in the treatment of multiple myeloma.
European journal of cancer (Oxford, England : 1990) 2011;47 Suppl 3():S306-8.
2011: Hara Episkopou; Soterios A Kyrtopoulos; Petros P Sfikakis; Meletios A Dimopoulos; Vassilis L Souliotis
The repair of melphalan-induced DNA adducts in the transcribed strand of active genes is subject to a strong polarity effect.
Mutation research 2011;714(1-2):78-87.
2011: Giannis Mountzios; Evangelos Bournakis; George Bozas; Meletios A Dimopoulos; Dimitrios Pectasides; Eirini Pectasides; Christos A Papadimitriou
Developments in the systemic treatment of endometrial cancer.
Critical reviews in oncology/hematology 2011;79(3):278-92.
2011: Meletios A Dimopoulos; Efstathios Kastritis
Bortezomib for AL amyloidosis: moving forward.
Blood 2011;118(4):827-8.
2011: Aristotelis Bamias; C Constantinidis; C Deliveliotis; A Karadimou; G Lainakis; E Manios; F Michas; N Zakopoulos; Meletios A Dimopoulos
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancer.
European journal of cancer (Oxford, England : 1990) 2011;47(11):1660-8.
2011: Ioannis Lymvaios; Iordanis Mourouzis; Dennis V Cokkinos; Meletios A Dimopoulos; Savvas T Toumanidis; Constantinos Pantos
Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association?
European journal of endocrinology / European Federation of Endocrine Societies 2011;165(1):107-14.
2011: Michele Cavo; Meletios A Dimopoulos; Brian G M Durie; Hermann Einsele; Gösta Gahrton; Sundar Jagannath; Hans E Johnsen; Nicolaus Kroeger; Sagar Lonial; Heinz Ludwig; Philippe Moreau; Ruben Niesvizky; Robert Z Orlowski; Antonio Palumbo; S Vincent Rajkumar; Paul G Richardson; Jesus San Miguel; Orhan Sezer; Pieter Sonneveld; David H Vesole; Kenneth C Anderson; Michel Attal; William Bensinger; P Leif Bergsagel; Joan Bladé; Mario Boccadoro
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
Blood 2011;117(23):6063-73.
2011: Evangelos Bournakis; Meletios A Dimopoulos; Aristotelis Bamias
Management of advanced bladder cancer in patients with impaired renal function.
Expert review of anticancer therapy 2011;11(6):931-9.
2011: Efstathios Kastritis; Marie-Christine Kyrtsonis; Evdoxia Hatjiharissi; Argyris Symeonidis; Evridiki Michalis; Panagiotis Repoussis; Konstantinos Tsatalas; Michael Michael; Anastasia Sioni; Zafiris Kartasis; Ekaterini Stefanoudaki; Michael Voulgarelis; Sosana Delimpasi; Maria Gavriatopoulou; Efstathios Koulieris; Dimitra Gika; Elissavet Vervesou; Kostas Konstantopoulos; Garyfalia Kokkini; Athanasios Zomas; Paraskevi Roussou; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Evangelos Terpos; Konstantinos Zervas; Meletios A Dimopoulos
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years.
American journal of hematology 2011;86(6):479-83.
2011: Evangelos Terpos; Lia A Moulopoulos; Meletios A Dimopoulos
Advances in imaging and the management of myeloma bone disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(14):1907-15.
2011: Alexandra Karadimou; Christos Kittas; Magdalini Migou; Alexandros Stratigos; Meletios A Dimopoulos; Afroditi Economidi; Aristotle Bamias
Leukocytoclastic vasculitis after long-term treatment with sunitinib: a case report.
Case reports in oncology 2011;4(2):385-91.
2011: Michel Delforge; Evangelos Terpos; Paul G Richardson; Ofer Shpilberg; Nuriet K Khuageva; Rudolf Schlag; Meletios A Dimopoulos; Martin Kropff; Ivan Spicka; Maria T Petrucci; Olga S Samoilova; Maria-Victoria Mateos; Hila Magen-Nativ; Hartmut Goldschmidt; Dixie Esseltine; Deborah S Ricci; Kevin Liu; William Deraedt; Andrew Cakana; Helgi van de Velde; Jesús F San Miguel
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.
European journal of haematology 2011;86(5):372-84.
2011: Meletios A Dimopoulos; Antonio Palumbo; M Attal; M Beksaç; F E Davies; M Delforge; H Einsele; R Hajek; Jean-Luc Harousseau; F Leal da Costa; Heinz Ludwig; U-H Mellqvist; G J Morgan; J F San-Miguel; S Zweegman; Pieter Sonneveld
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement.
Leukemia 2011;25(5):749-60.
2011: Dimitrios Christoulas; Charis Matsouka; Ioannis Chatzinikolaou; Despoina Barmparoussi; Meletios A Dimopoulos; Christos A Papadimitriou
Relapse of ovarian cancer with bone marrow infiltration and concurrent emergence of therapy-related acute myeloid leukemia: a case report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(11):e295-6.
2011: Evangelos Bournakis; Eleni Efstathiou; Andreas Varkaris; Sijin Wen; Michael Chrisofos; Charalambos Deliveliotis; Christos Alamanis; Ioannis Anastasiou; Constantinos Constantinides; Aristotelis Bamias; Meletios A Dimopoulos
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival.
Anticancer research 2011;31(4):1475-82.
2011: Paris A Kosmidis; George Fountzilas; A G Eleftheraki; Haralabos P Kalofonos; G Pentheroudakis; Dimosthenis Skarlos; Meletios A Dimopoulos; Dimitrios Bafaloukos; D Pectasides; Epaminondas Samantas; J Boukovinas; S Lambaki; N Katirtzoglou; C Bakogiannis; K N Syrigos
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):827-34.
2011: Sandra Grass; Klaus-Dieter Preuss; Alexandra Wikowicz; Evangelos Terpos; Marita Ziepert; Diana Nikolaus; Yin Yang; Natalie Fadle; Evi Regitz; Meletios A Dimopoulos; Steven P Treon; Zachary R Hunter; Michael Pfreundschuh
Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
Blood 2011;117(10):2918-23.
2011: Efstathios Kastritis; Evangelos Terpos; Meletios A Dimopoulos
Emerging drugs for Waldenström's macroglobulinemia.
Expert opinion on emerging drugs 2011;16(1):45-57.
2011: Ioannis Mountzios; Evangelos Bournakis; Eleni Efstathiou; Andreas Varkaris; Sijin Wen; Michael Chrisofos; Charalambos Deliveliotis; Christos Alamanis; Ioannis Anastasiou; Constantinos Constantinides; Alexandra Karadimou; Marinos Tsiatas; Christos Papadimitriou; Aristotelis Bamias; Meletios A Dimopoulos
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer.
Urology 2011;77(3):682-7.
2011: Evangelos Terpos; Meletios A Dimopoulos
Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications.
Cancer immunology, immunotherapy : CII 2011;60(3):305-17.
2011: Aristotelis Bamias; Gerassimos Aravantinos; Ioannis Kastriotis; Gerassimos Alivizatos; Ioannis Anastasiou; Christos Christodoulou; Reveka Gyftaki; Haralambos P Kalofonos; Meletios A Dimopoulos
Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group.
Urologic oncology 2011;29(2):189-93.
2011: Efstathios Kastritis; Maria Gavriatopoulou; Marie-Christine Kyrtsonis; Michael Michael; Evdoxia Hadjiharissi; Argyris Symeonidis; Evridiki Michalis; Panagiotis Repoussis; Konstantinos Tsatalas; Anastasia Sioni; Zafiris Kartasis; Ekaterini Stefanoudaki; Michael Voulgarelis; Sosana Delimpasi; Dimitra Gika; Elissavet Vervesou; Konstantinos Konstantopoulos; Garyfalia Kokkini; Athanasios Zomas; Paraskevi Roussou; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Evangelos Terpos; Konstantinos Zervas; Meletios A Dimopoulos
Prognostication of the high-risk WM patient.
Clinical lymphoma, myeloma & leukemia 2011;11(1):127-9.
2011: Evangelos Terpos; Meletios A Dimopoulos; James Berenson
Established role of bisphosphonate therapy for prevention of skeletal complications from myeloma bone disease.
Critical reviews in oncology/hematology 2011;77 Suppl 1():S13-23.
2011: Jesús F San Miguel; Meletios A Dimopoulos; Edward A Stadtmauer; S Vincent Rajkumar; David Siegel; Marie-Laure Bravo; Marta Olesnyckyj; Robert D Knight; Jerome B Zeldis; Jean-Luc Harousseau; Donna M Weber
Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.
Clinical lymphoma, myeloma & leukemia 2011;11(1):38-43.
2011: Aristotelis Bamias; Aristidis Antsaklis; Christina Bamia; Dimitrios Haidopoulos; Alexandra Karadimou; Alexandros Rodolakis; Nikolaos Soupos; Nikolaos Thomakos; George Vlahos; Flora Zagouri; Meletios A Dimopoulos
A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcome.
Oncology 2011;81(5-6):365-71.
2011: George Lainakis; Flora Zagouri; Efstathios Kastritis; Theodoros N Sergentanis; George Bozas; Meletios A Dimopoulos; Christos A Papadimitriou
Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience.
Tumori 2011;97(1):25-9.
2011: Christos A Papadimitriou; Pavlos Papakostas; Maria Karina; Lia Malettou; Meletios A Dimopoulos; George Pentheroudakis; Epaminondas Samantas; Aristotelis Bamias; Dimosthenis Miliaras; George Basdanis; Nikolaos Xiros; George Klouvas; Dimitrios Bafaloukos; Georgia Kafiri; Irene Papaspirou; Dimitrios Pectasides; Charisios Karanikiotis; Theofanis Economopoulos; Ioannis Efstratiou; Ippokratis Korantzis; Nikolaos Pisanidis; Thomas Makatsoris; Fotini Matsiakou; Gerasimos Aravantinos; Haralabos P Kalofonos; George Fountzilas
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
BMC medicine 2011;9():10.
2011: Meletios A Dimopoulos; Jesus F San-Miguel; Kenneth C Anderson
Emerging therapies for the treatment of relapsed or refractory multiple myeloma.
European journal of haematology 2011;86(1):1-15.
2011: Meletios A Dimopoulos; Maria-Victoria Mateos; Paul G Richardson; Rudolf Schlag; Nuriet K Khuageva; Ofer Shpilberg; Martin Kropff; Ivan Spicka; Antonio Palumbo; Ka Lung Wu; Dixie Esseltine; Kevin Liu; William Deraedt; Andrew Cakana; Helgi Van De Velde; Jesús F San Miguel
Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study.
European journal of haematology 2011;86(1):23-31.
2010: Efstathios Kastritis; Meletios A Dimopoulos
High dose melphalan in primary systemic amyloidosis: status quo?
Leukemia & lymphoma 2010;51(12):2149-51.
2010: Meletios A Dimopoulos; Evangelos Terpos; Asher Chanan-Khan; Nelson Leung; Heinz Ludwig; Sundar Jagannath; Ruben Niesvizky; Sergio Giralt; Jean-Paul Fermand; Joan Bladé; Raymond L Comenzo; Orhan Sezer; Antonio Palumbo; Jean-Luc Harousseau; Paul G Richardson; Bart Barlogie; Kenneth C Anderson; Pieter Sonneveld; Patrizia Tosi; Michele Cavo; S Vincent Rajkumar; Brian G M Durie; Jésus San Miguel
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):4976-84.
2010: Jean-Luc Harousseau; Antonio Palumbo; Paul G Richardson; Rudolf Schlag; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Alain Kentos; Michele Cavo; Anatoly Golenkov; Mieczyslaw Komarnicki; Maria-Victoria Mateos; Dixie Esseltine; Andrew Cakana; Kevin Liu; William Deraedt; Helgi van de Velde; Jesús F San Miguel
Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone.
Blood 2010;116(19):3743-50.
2010: Michel Delforge; Joan Bladé; Meletios A Dimopoulos; Thierry Facon; Martin Kropff; Heinz Ludwig; Antonio Palumbo; Philip Van Damme; Jesús F San Miguel; Pieter Sonneveld
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues.
The lancet oncology 2010;11(11):1086-95.
2010: Evangelos Eleutherakis-Papaiakovou; Evangelos Kostis; Magda Migkou; Dimitrios Christoulas; Evangelos Terpos; Maria Gavriatopoulou; Maria Roussou; Evangelos Bournakis; Efstathios Kastritis; Eleni Efstathiou; Meletios A Dimopoulos; Christos A Papadimitriou
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
American journal of hematology 2010;85(11):863-7.
2010: Meletios A Dimopoulos; Evangelos Terpos
Multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 7():vii143-50.
2010: Evangelos Terpos; Meletios A Dimopoulos
Intravenous pamidronate for myeloma bone disease: can the dose be lowered?
The lancet oncology 2010;11(10):913-4.
2010: Evangelos Terpos; Meletios A Dimopoulos; O Sezer; D Roodman; N Abildgaard; R Vescio; P Tosi; R Garcia-Sanz; F Davies; A Chanan-Khan; Antonio Palumbo; Pieter Sonneveld; M T Drake; Jean-Luc Harousseau; Kenneth C Anderson; B G M Durie
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.
Leukemia 2010;24(10):1700-12.
2010: Meletios A Dimopoulos; Efstathios Kastritis; D Christoulas; M Migkou; M Gavriatopoulou; M Gkotzamanidou; M Iakovaki; Charis Matsouka; D Mparmparoussi; Maria Roussou; Eleni Efstathiou; Evangelos Terpos
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies.
Leukemia 2010;24(10):1769-78.
2010: Maria Roussou; Efstathios Kastritis; Dimitrios Christoulas; Magdalini Migkou; Maria Gavriatopoulou; Irini Grapsa; Erasmia Psimenou; Dimitra Gika; Evangelos Terpos; Meletios A Dimopoulos
Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents.
Leukemia research 2010;34(10):1395-7.
2010: Jean-Luc Harousseau; Meletios A Dimopoulos; Michael Wang; Alessandro Corso; Christine Chen; Michel Attal; Andrew Spencer; Zhinuan Yu; Marta Olesnyckyj; Jerome B Zeldis; Robert D Knight; Donna M Weber
Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma.
Haematologica 2010;95(10):1738-44.
2010: Efstathios Kastritis; Marie-Christine Kyrtsonis; Evdoxia Hadjiharissi; Argyris Symeonidis; Evridiki Michalis; Panagiotis Repoussis; Costas Tsatalas; Michael Michael; Anastasia Sioni; Zafiris Kartasis; Ekaterini Stefanoudaki; Michael Voulgarelis; Sossana Delimpasi; Maria Gavriatopoulou; Efstathios Koulieris; Dimitra Gika; Athanasios Zomas; Paraskevi Roussou; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Evangelos Terpos; Konstantinos Zervas; Meletios A Dimopoulos
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH).
Leukemia research 2010;34(10):1340-3.
2010: Efstathios Kastritis; Maria Roussou; Michalis Michael; Maria Gavriatopoulou; Evridiki Michalis; Magdalini Migkou; Sossana Delimpasi; Marie-Christine Kyrtsonis; Dimitrios Gogos; Konstantinos Liapis; Evangelia Charitaki; Panagiotis Repousis; Evangelos Terpos; Meletios A Dimopoulos
High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients.
British journal of haematology 2010;150(5):587-91.
2010: Sundar Jagannath; Meletios A Dimopoulos; Sagar Lonial
Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myeloma.
Leukemia research 2010;34(9):1111-8.
2010: M Vassilakopoulou; Giannis Mountzios; C Papamechael; Athanassios D Protogerou; Konstantinos Aznaouridis; P Katsichti; Kyriaki Venetsanou; Meletios A Dimopoulos; Ignatios Ikonomidis; Christos A Papadimitriou
Paclitaxel chemotherapy and vascular toxicity as assessed by flow-mediated and nitrate-mediated vasodilatation.
Vascular pharmacology 2010;53(3-4):115-21.
2010: Evangelos Terpos; Eirini Katodritou; Maria Roussou; Anastasia Pouli; Evridiki Michalis; Sosana Delimpasi; Agapi Parcharidou; Zafiris Kartasis; Athanasios Zomas; Argyris Symeonidis; Nora Viniou; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Konstantinos Zervas; Meletios A Dimopoulos
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents.
European journal of haematology 2010;85(2):114-9.
2010: James R Berenson; Kenneth C Anderson; Robert A Audell; Ralph V Boccia; Morton Coleman; Meletios A Dimopoulos; Matthew T Drake; Rafael Fonseca; Jean-Luc Harousseau; Douglas Joshua; Sagar Lonial; Ruben Niesvizky; Antonio Palumbo; G David Roodman; Jesus F San-Miguel; Seema Singhal; Donna M Weber; Maurizio Zangari; Eric Wirtschafter; Ori Yellin; Robert A Kyle
Monoclonal gammopathy of undetermined significance: a consensus statement.
British journal of haematology 2010;150(1):28-38.
2010: Evangelos Terpos; D Christoulas; P Kokkoris; Konstantinos Anargyrou; M Gavriatopoulou; M Migkou; Konstantinos Tsionos; Meletios A Dimopoulos
Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(7):1561-2.
2010: Meletios A Dimopoulos; Dimitrios Christoulas; Maria Roussou; Efstathios Kastritis; Magdalini Migkou; Maria Gavriatopoulou; Charis Matsouka; Despoina Mparmparoussi; Erasmia Psimenou; Irini Grapsa; Eleni Efstathiou; Evangelos Terpos
Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment.
European journal of haematology 2010;85(1):1-5.
2010: L A Moulopoulos; Meletios A Dimopoulos; D Christoulas; Efstathios Kastritis; Dimitra Anagnostou; Andreas Koureas; Maria Roussou; M Gavriatopoulou; M Migkou; M Iakovaki; M Gkotzamanidou; Anna Tasidou; Evangelos Terpos
Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents.
Leukemia 2010;24(6):1206-12.
2010: Maria-Victoria Mateos; Paul G Richardson; Rudolf Schlag; Nuriet K Khuageva; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Ivan Spicka; Maria T Petrucci; Antonio Palumbo; Olga S Samoilova; Anna Dmoszynska; Kudrat M Abdulkadyrov; Rik Schots; Bin Jiang; Dixie Esseltine; Kevin Liu; Andrew Cakana; Helgi van de Velde; Jesús F San Miguel
Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2259-66.
2010: Aristotelis Bamias; M Karina; P Papakostas; I Kostopoulos; M Bobos; G Vourli; Epaminondas Samantas; Ch Christodoulou; George Pentheroudakis; D Pectasides; Meletios A Dimopoulos; George Fountzilas
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer.
Cancer chemotherapy and pharmacology 2010;65(6):1009-21.
2010: Meletios A Dimopoulos; Christine Chen; Efstathios Kastritis; Maria Gavriatopoulou; Steven P Treon
Bortezomib as a treatment option in patients with Waldenström macroglobulinemia.
Clinical lymphoma, myeloma & leukemia 2010;10(2):110-7.
2010: Evangelos Terpos; Meletios A Dimopoulos; Vikas Shrivastava; Kim Leitzel; Dimitrios Christoulas; Magdalini Migkou; Maria Gavriatopoulou; Konstantinos Anargyrou; Peter Hamer; Efstathios Kastritis; Walter Carney; Allan Lipton
High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents.
Leukemia research 2010;34(3):399-402.
2010: Efstathios Kastritis; Ashutosh D Wechalekar; Meletios A Dimopoulos; Giampaolo Merlini; Philip N Hawkins; Vittorio Perfetti; Julian D Gillmore; Giovanni Palladini
Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(6):1031-7.
2010: Michael Michael; Efstathios Kastritis; Sossana Delimpassi; Evridiki Michalis; Panagiotis Repoussis; Marie-Christine Kyrtsonis; Eirini Katodritou; Nicolaos Anagnostopoulos; Konstantinos Zervas; Meletios A Dimopoulos
Clinical characteristics and outcome of primary systemic light-chain amyloidosis in Greece.
Clinical lymphoma, myeloma & leukemia 2010;10(1):56-61.
2010: George Bozas; Evangelos Terpos; Dimitra Gika; Alexandra Karadimou; Meletios A Dimopoulos; Aristotelis Bamias
Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010;20(2):248-54.
2010: Nikos G Gavalas; Alexandra Karadimou; Meletios A Dimopoulos; Aristotelis Bamias
Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.
Clinical & developmental immunology 2010;2010():791603.
2010: Meletios A Dimopoulos; Evangelos Terpos
Renal insufficiency and failure.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2010;2010():431-6.
2010: Flora Zagouri; Meletios A Dimopoulos; E Bournakis; Christos A Papadimitriou
Molecular markers in epithelial ovarian cancer: their role in prognosis and therapy.
European journal of gynaecological oncology 2010;31(3):268-77.
2010: Paraskevi Savvari; Charis Matsouka; Despoina Barbaroussi; Dimitrios Christoulas; Nikitas Nikitas; Meletios A Dimopoulos; Christos A Papadimitriou
Burkitt's lymphoma in pregnancy with bilateral breast involvement: case report with review of the literature.
Onkologie 2010;33(8-9):461-4.
2010: Aristotle Bamias; Evangelos Terpos; Meletios A Dimopoulos
Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
Onkologie 2010;33(6):288-9.
2010: Aristotelis Bamias; Alexandra Karadimou; Sofia Lampaki; George Lainakis; Lia Malettou; Eleni Timotheadou; Konstantinos Papazisis; Charalambos Andreadis; Loukas Kontovinis; Ioannis Anastasiou; Kostas Stravodimos; Ioannis Xanthakis; Andreas Skolarikos; Christos Christodoulou; Kostas Syrigos; Christos Papandreou; Evangelia Razi; Urania Dafni; George Fountzilas; Meletios A Dimopoulos
Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model.
BMC cancer 2010;10():45.
2010: Flora Zagouri; George Bozas; Eftichia Kafantari; Marinos Tsiatas; Nikitas Nikitas; Meletios A Dimopoulos; Christos A Papadimitriou
Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?
Obstetrics and gynecology international 2010;2010():749579.
2010: Maurizio Zangari; Guido Tricot; Latha Polavaram; Fenghuang Zhan; Ashlie Finlayson; Robert Knight; Tommy Fu; Donna Weber; Meletios A Dimopoulos; Ruben Niesvizky; Louis Fink
Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):132-5.
2009: Meletios A Dimopoulos; Paul G Richardson; Rudolf Schlag; Nuriet K Khuageva; Ofer Shpilberg; Efstathios Kastritis; Martin Kropff; Maria T Petrucci; Michel Delforge; Julia Alexeeva; Rik Schots; Tamás Masszi; Maria-Victoria Mateos; William Deraedt; Kevin Liu; Andrew Cakana; Helgi van de Velde; Jesús F San Miguel
VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6086-93.
2009: Meletios A Dimopoulos; Evangelos Terpos
Hematology: first-line bortezomib benefits patients with multiple myeloma.
Nature reviews. Clinical oncology 2009;6(12):683-5.
2009: Eirini Katodritou; Meletios A Dimopoulos; Konstantinos Zervas; Evangelos Terpos
Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma.
Cancer treatment reviews 2009;35(8):738-43.
2009: Meletios A Dimopoulos; C Chen; A Spencer; R Niesvizky; M Attal; Edward A Stadtmauer; M T Petrucci; Z Yu; Marta Olesnyckyj; Jerome B Zeldis; Robert D Knight; Donna M Weber
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma.
Leukemia 2009;23(11):2147-52.
2009: Maria Roussou; Anna Tasidou; Meletios A Dimopoulos; Efstathios Kastritis; M Migkou; D Christoulas; M Gavriatopoulou; F Zagouri; Charis Matsouka; D Anagnostou; Evangelos Terpos
Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma.
Leukemia 2009;23(11):2177-81.
2009: Paraskevi Savvari; Panagiotis Peitsidis; Maria Alevizaki; Meletios A Dimopoulos; Aristidis Antsaklis; Christos A Papadimitriou
Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review.
Onkologie 2009;32(8-9):517-23.
2009: Meletios A Dimopoulos; E Terpos; R L Comenzo; P Tosi; M Beksac; O Sezer; D Siegel; H Lokhorst; S Kumar; S V Rajkumar; R Niesvizky; L A Moulopoulos; B G M Durie
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
Leukemia 2009;23(9):1545-56.
2009: Sylvianna Georgaki; Margarita Skopeliti; Marinos Tsiatas; Katerina A Nicolaou; Kyriaki Ioannou; Alan Husband; Aristotelis Bamias; Meletios A Dimopoulos; Andreas I Constantinou; Ourania E Tsitsilonis
Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivo.
Journal of cellular and molecular medicine 2009;13(9B):3929-38.
2009: Dimitrios Christoulas; Evangelos Terpos; Meletios A Dimopoulos
Pathogenesis and management of myeloma bone disease.
Expert review of hematology 2009;2(4):385-98.
2009: Meletios A Dimopoulos; Maria Roussou; Maria Gavriatopoulou; Flora Zagouri; Magdalini Migkou; Charis Matsouka; Despina Barbarousi; Dimitrios Christoulas; Erasmia Primenou; Irini Grapsa; Evangelos Terpos; Efstathios Kastritis
Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
Clinical lymphoma & myeloma 2009;9(4):302-6.
2009: Evangelos Terpos; O Sezer; P I Croucher; R García-Sanz; Mario Boccadoro; J San Miguel; J Ashcroft; J Bladé; M Cavo; M Delforge; Meletios A Dimopoulos; T Facon; M Macro; A Waage; Pieter Sonneveld
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1303-17.
2009: Giannis Mountzios; Meletios A Dimopoulos; Aristotelis Bamias; G Vourli; Haralambos Kalofonos; Gerasimos Aravantinos; George Fountzilas; Christos A Papadimitriou
Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1362-8.
2009: Aristotelis Bamias; G Lainakis; E Manios; E Koroboki; R Gyftaki; N Zakopoulos; Meletios A Dimopoulos
Diagnosis and management of hypertension in advanced renal cell carcinoma: prospective evaluation of an algorithm in patients treated with sunitinib.
Journal of chemotherapy (Florence, Italy) 2009;21(3):347-50.
2009: Edward A Stadtmauer; Donna M Weber; Ruben Niesvizky; Andrew Belch; Miles H Prince; Jesús F San Miguel; Thierry Facon; Marta Olesnyckyj; Zhinuan Yu; Jerome B Zeldis; Robert D Knight; Meletios A Dimopoulos
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.
European journal of haematology 2009;82(6):426-32.
2009: Efstathios Kastritis; Konstantinos Zervas; Argyris Symeonidis; Evangelos Terpos; S Delimbassi; Nikolaos Anagnostopoulos; Evridiki Michali; Athanasios Zomas; Eirini Katodritou; Dimitra Gika; Anastasia Pouli; D Christoulas; Maria Roussou; Z Kartasis; Theofanis Economopoulos; Meletios A Dimopoulos
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).
Leukemia 2009;23(6):1152-7.
2009: Aristotle Bamias; George Lainakis; Efstathios Manios; Eleni Koroboki; Alexandra Karadimou; Nikos Zakopoulos; Meletios A Dimopoulos
Could rigorous diagnosis and management of hypertension reduce cardiac events in patients with renal cell carcinoma treated with tyrosine kinase inhibitors?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(15):2567-9; author reply 2569-70.
2009: Hara Episkopou; Soterios A Kyrtopoulos; Petros P Sfikakis; Maria Fousteri; Meletios A Dimopoulos; Leon H F Mullenders; VASSILIS SOULIOTIS
Association between transcriptional activity, local chromatin structure, and the efficiencies of both subpathways of nucleotide excision repair of melphalan adducts.
Cancer research 2009;69(10):4424-33.
2009: George Fountzilas; Urania Dafni; Meletios A Dimopoulos; A Koutras; Dimosthenis Skarlos; Pavlos Papakostas; Helen Gogas; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; Epaminondas Samantas; Evangelos Briasoulis; Dimitrios Pectasides; N Maniadakis; F Matsiakou; Gerasimos Aravantinos; Christos Papadimitriou; Maria Karina; Christos Christodoulou; Paris A Kosmidis; Haralabos P Kalofonos
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.
Breast cancer research and treatment 2009;115(1):87-99.
2009: Pierre Morel; Alain Duhamel; Paolo Gobbi; Meletios A Dimopoulos; Madhav V Dhodapkar; Jason McCoy; John Crowley; Enrique M Ocio; Ramon Garcia-Sanz; Steven P Treon; Veronique Leblond; Robert A Kyle; Bart Barlogie; Giampaolo Merlini
International prognostic scoring system for Waldenstrom macroglobulinemia.
Blood 2009;113(18):4163-70.
2009: Efstathios Kastritis; Antonio Palumbo; Meletios A Dimopoulos
Treatment of relapsed/refractory multiple myeloma.
Seminars in hematology 2009;46(2):143-57.
2009: Meletios A Dimopoulos; Michel Attal
Multiple myeloma in the era of novel agents.
Seminars in hematology 2009;46(2):107-9.
2009: Meletios A Dimopoulos; Efstathios Kastritis; Maria Roussou; Evangelos Eleutherakis-Papaiakovou; Magdalini Migkou; Maria Gavriatopoulou; Anna Tassidou; Evangelos Terpos
Rituximab-based treatments in Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 2009;9(1):59-61.
2009: Efstathios Kastritis; Konstantinos Zervas; Panagiotis Repoussis; Evridiki Michali; Eirini Katodrytou; Athanasios Zomas; Argiris Simeonidis; Evangelos Terpos; Sossana Delimbassi; Amalia Vassou; Dimitra Gika; Meletios A Dimopoulos
Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.
Clinical lymphoma & myeloma 2009;9(1):50-2.
2009: Panteleimon Kountourakis; Amanda Psyrri; Andreas Scorilas; Sonia Markakis; Diane Kowalski; Robert L Camp; Eleftherios P Diamandis; Meletios A Dimopoulos
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
Thrombosis and haemostasis 2009;101(3):541-6.
2009: Evangelos Terpos; Eirini Katodritou; Evangelos Tsiftsakis; Efstathios Kastritis; Dimitrios Christoulas; Anastasia Pouli; Eurydiki Michalis; Evgenia Verrou; Konstantinos Anargyrou; Konstantinos Tsionos; Meletios A Dimopoulos; Konstantinos Zervas
Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.
Haematologica 2009;94(3):372-9.
2009: Efstathios Kastritis; Magdalini Migkou; Maria Gavriatopoulou; Panos Zirogiannis; Valsamakis Hadjikonstantinou; Meletios A Dimopoulos
Treatment of light chain deposition disease with bortezomib and dexamethasone.
Haematologica 2009;94(2):300-2.
2009: Christos A Papadimitriou; Sophia Markaki; Evangelos Lianos; P Peitsidis; G Vourli; N Nikitas; George Vlachos; Alexandros Rodolakis; Aris Antsaklis; Meletios A Dimopoulos
Clinicopathological features of primary fallopian tube carcinoma: a single institution experience.
European journal of gynaecological oncology 2009;30(4):389-95.
2009: Christos A Papadimitriou; Haralambos Kalofonos; Flora Zagouri; Pavlos Papakostas; George Bozas; Thomas Makatsoris; Meletios A Dimopoulos; George Fountzilas
Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.
Oncology 2009;77(3-4):212-6.
2009: Efstathios Kastritis; Andreas Charidimou; Andreas Varkaris; Meletios A Dimopoulos
Targeted therapies in multiple myeloma.
Targeted oncology 2009;4(1):23-36.
2009: Efstathios Kastritis; Samuel Murray; Fani Kyriakou; Maria Horti; Nicolaos Tamvakis; Nikolaos Kavantzas; Efstratios S Patsouris; Aphrodite Noni; Sofia Legaki; Meletios A Dimopoulos; Aristotelis Bamias
Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication.
International journal of cancer. Journal international du cancer 2009;124(1):103-8.
2008: Angelos Koutras; K T Kalogeras; Meletios A Dimopoulos; R M Wirtz; U Dafni; E Briasoulis; Dimitrios Pectasides; Helen Gogas; C Christodoulou; Gerasimos Aravantinos; G Zografos; E Timotheadou; Pavlos Papakostas; H Linardou; E Razis; Theofanis Economopoulos; Haralabos P Kalofonos; G Fountzilas
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
British journal of cancer 2008;99(11):1775-85.
2008: Eftychia Kafantari; Maria Sotiropoulou; Petros Sfikakis; Konstantinos Dimitrakakis; Flora Zagouri; Konstantinos Mandrekas; Stavros Dimopoulos; Meletios A Dimopoulos; Christos A Papadimitriou
Giant cell arteritis of the breast and breast cancer: paraneoplastic manifestation or concomitant disease? A case report.
Onkologie 2008;31(12):685-8.
2008: Michael Wang; Meletios A Dimopoulos; Christine Chen; M Teresa Cibeira; Michel Attal; Andrew Spencer; S Vincent Rajkumar; Zhinuan Yu; Marta Olesnyckyj; Jerome B Zeldis; Robert D Knight; Donna M Weber
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure.
Blood 2008;112(12):4445-51.
2008: Meletios A Dimopoulos; Efstathios Kastritis
Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma.
Nature clinical practice. Oncology 2008;5(12):690-1.
2008: Panteleimon Kountourakis; Amanda Psyrri; Andreas Scorilas; Robert L Camp; Sonia Markakis; Diane Kowalski; Eleftherios P Diamandis; Meletios A Dimopoulos
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).
Cancer science 2008;99(11):2224-9.
2008: Gerasimos Aravantinos; George Fountzilas; Aristotelis Bamias; Irene Grimani; Spyridon Rizos; Haralabos P Kalofonos; Dimosthenis V Skarlos; Theofanis Economopoulos; Paris A Kosmidis; George P Stathopoulos; Evangelos Briasoulis; Dimitrios Pectasides; Epaminondas Samantas; Eleni Timotheadou; Christos Papadimitriou; Alexandros Papanikolaou; Adimchi Onyenadum; Pavlos Papakostas; Dimitrios Bafaloukos; Meletios A Dimopoulos
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
European journal of cancer (Oxford, England : 1990) 2008;44(15):2169-77.
2008: Christos A Papadimitriou; George Fountzilas; Dimitrios Bafaloukos; George Bozas; Haralambos Kalofonos; Dimitrios Pectasides; Gerasimos Aravantinos; Aristotelis Bamias; Meletios A Dimopoulos
Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Gynecologic oncology 2008;111(1):27-34.
2008: Angelos Koutras; George Fountzilas; Urania Dafni; Meletios A Dimopoulos; Dimitrios Pectasides; George Klouvas; Pavlos Papakostas; Paris A Kosmidis; Epaminondas Samantas; Helen Gogas; Evangelos Briasoulis; Georgia Vourli; Theodoros Petsas; Nikolaos Xiros; Haralabos P Kalofonos
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.
Anticancer research 2008;28(5B):2913-20.
2008: Meletios A Dimopoulos; Efstathios Kastritis
The role of novel drugs in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 7():vii121-7.
2008: Jesús F San Miguel; Rudolf Schlag; Nuriet K Khuageva; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; Ivan Spicka; Maria T Petrucci; Antonio Palumbo; Olga S Samoilova; Anna Dmoszynska; Kudrat M Abdulkadyrov; Rik Schots; Bin Jiang; Maria-Victoria Mateos; Kenneth C Anderson; Dixie Esseltine; Kevin Liu; Andrew Cakana; Helgi van de Velde; Paul G Richardson
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
The New England journal of medicine 2008;359(9):906-17.
2008: Meletios A Dimopoulos; Efstathios Kastritis; L Rosinol; J Bladé; Heinz Ludwig
Pathogenesis and treatment of renal failure in multiple myeloma.
Leukemia 2008;22(8):1485-93.
2008: Aristotelis Bamias; F Kyriakou; M Chorti; Nikolaos Kavantzas; A Noni; Aspasia Kyroudi-Voulgari; D Rontoyianni; Efstathios Kastritis; N Xiros; Efstratios Patsouris; S Murray; N Tamvakis; Meletios A Dimopoulos
Microvessel density (MVD) and cyclooxygenase-2 (COX-2)/ beta-catenin interaction are associated with relapse in patients with transitional carcinoma receiving adjuvant chemotherapy with paclitaxel/carboplatin: a hellenic cooperative oncology group (HECOG) study.
Anticancer research 2008;28(4C):2479-86.
2008: Meletios A Dimopoulos; Efstathios Kastritis; S V Rajkumar
Treatment of plasma cell dyscrasias with lenalidomide.
Leukemia 2008;22(7):1343-53.
2008: Christos A Papadimitriou; Dimitrios Bafaloukos; George Bozas; Haralambos Kalofonos; Paris Kosmidis; Gerasimos Aravantinos; George Fountzilas; Meletios A Dimopoulos
Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Gynecologic oncology 2008;110(1):87-92.
2008: Amanda Psyrri; P Kountourakis; Andreas Scorilas; Sonia Markakis; Robert L Camp; Diane Kowalski; Eleftherios P Diamandis; Meletios A Dimopoulos
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(7):1271-7.
2008: George Lainakis; Antoniou Nikos; Alivizatos Gerassimos; Chrisofos Michael; Mitsoyiannis Iraklis; Livadas Konstantinos; Varkarakis Ioannis; Katsifotis Harilaos; Meletios A Dimopoulos; Aristotelis Bamias
Biweekly doxorubicin/ketoconazole as second-line treatment in docetaxel-resistant, hormone-refractory prostate cancer.
Urology 2008;71(6):1181-5.
2008: Aristotelis Bamias; Meletios A Dimopoulos
Editorial comment on: new treatment approaches for prostate cancer based on peptide analogues.
European urology 2008;53(5):899-900.
2008: George Papaxoinis; George Fountzilas; DEMETRA RONTOGIANNI; Meletios A Dimopoulos; Nicholas Pavlidis; Costas Tsatalas; Dimitrios Pectasides; Nikolaos Xiros; Theofanis Economopoulos
Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):780-6.
2008: Maria Roussou; Stavros K Dimopoulos; Meletios A Dimopoulos; Maria I Anastasiou-Nana
Wegener's granulomatosis presenting as a renal mass.
Urology 2008;71(3):547.e1-2.
2008: Konstantinos Anargyrou; Evangelos Terpos; Theodoros P Vassilakopoulos; Anastasia Pouli; Sotirios Sachanas; Tatiana Tzenou; Stavroula Masouridis; Dimitrios Christoulas; Maria K Angelopoulou; Evangelia M Dimitriadou; Christina Kalpadakis; Konstantinos Tsionos; Panayiotis Panayiotidis; Meletios A Dimopoulos; Gerassimos A Pangalis; Marie-Christine Kyrtsonis
Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib.
Haematologica 2008;93(3):451-4.
2008: Christos Papadimitriou; U Dafni; Athanasios Anagnostopoulos; George Vlachos; Zannis Voulgaris; Alexandros Rodolakis; Gerasimos Aravantinos; Aristotelis Bamias; George Bozas; E Kiosses; G M Gourgoulis; Eleni Efstathiou; Meletios A Dimopoulos
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial.
Bone marrow transplantation 2008;41(6):547-54.
2008: Aristotelis Bamias; Vassiliki Koutsoukou; Evangelos Terpos; Marinos L Tsiatas; Christina Liakos; Ourania E Tsitsilonis; Alexandros Rodolakis; Zannis Voulgaris; George Vlahos; Theoharis Papageorgiou; George V Papatheodoridis; Athanasios Archimandritis; Aris Antsaklis; Meletios A Dimopoulos
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Gynecologic oncology 2008;108(2):421-7.
2008: Aristotelis Bamias; George Bozas; Nikolaos Antoniou; Iraklis Poulias; Harilaos Katsifotis; Andreas Skolarikos; Dionisios Mitropoulos; Christos Alamanis; Gerasimos Alivizatos; Haralambos Deliveliotis; Meletios A Dimopoulos
Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.
European urology 2008;53(2):323-31.
2008: Christos A Papadimitriou; Panagiotis Peitsidis; George Bozas; Irene Grimani; George Vlahos; Alexandros Rodolakis; Evangelos Lianos; Aristotelis Bamias; George Lainakis; Meletios A Dimopoulos
Paclitaxel- and platinum-based postoperative chemotherapy for primary fallopian tube carcinoma: a single institution experience.
Oncology 2008;75(1-2):42-8.
2008: Paris A Kosmidis; Haralabos P Kalofonos; Christos Christodoulou; Konstantinos Syrigos; Thomas Makatsoris; Dimosthenis Skarlos; C Bakogiannis; Costas Nicolaides; Dimitrios Bafaloukos; Aristotelis Bamias; Epaminondas Samantas; Nikolaos Xiros; Ioannis Boukovinas; George Fountzilas; Meletios A Dimopoulos
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(1):115-22.
2007: Aristotelis Bamias; Gerasimos Aravantinos; Charalambos Deliveliotis; Anastasios Thanos; George Klouvas; Nikolaos Antoniou; Iraklis Poulias; Thomas Makatsoris; Epaminondas Samantas; Meletios A Dimopoulos
Two cycles of etoposide/cisplatin cured all patients with stage I testicular seminoma: risk-adapted protocol of the Hellenic Cooperative Oncology Group.
Urology 2007;70(6):1179-83.
2007: Efstathios Kastritis; Meletios A Dimopoulos
Thalidomide in the treatment of multiple myeloma.
Best practice & research. Clinical haematology 2007;20(4):681-99.
2007: Efstathios Kastritis; Meletios A Dimopoulos
How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomide.
Leukemia & lymphoma 2007;48(12):2295-7.
2007: Efstathios Kastritis; Constantine S Mitsiades; Meletios A Dimopoulos; Paul G Richardson
Management of relapsed and relapsed refractory myeloma.
Hematology/oncology clinics of North America 2007;21(6):1175-215, x.
2007: Meletios A Dimopoulos; Andrew Spencer; Michael Attal; H Miles Prince; Jean-Luc Harousseau; Anna Dmoszynska; Jesus San Miguel; Andrzej Hellmann; Thierry Facon; Robin Foà; Alessandro Corso; Zvenyslava Masliak; Marta Olesnyckyj; Zhinuan Yu; John Patin; Jerome B Zeldis; Robert D Knight
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.
The New England journal of medicine 2007;357(21):2123-32.
2007: Meletios A Dimopoulos; VASSILIS SOULIOTIS; Athanasios Anagnostopoulos; Christina Bamia; Anastasia Pouli; Ioannis Baltadakis; Evangelos Terpos; Soterios A Kyrtopoulos; Petros P Sfikakis
Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma.
Haematologica 2007;92(11):1505-12.
2007: Stephanos Karagiannis; Christos A Papadimitriou; Maria Sotiropoulou; Fotios Dimopoulos; Helen Chrysanthopoulou; Meletios A Dimopoulos; Spyros Michopoulos
Squamous cell esophageal carcinoma as a second primary malignancy in a woman with epithelial ovarian cancer.
Digestive diseases and sciences 2007;52(11):3099-101.
2007: Hariklia Gakiopoulou; Penelope Korkolopoulou; Georgia Levidou; Irene Thymara; Angelica Saetta; Christina Piperi; Nikolaos Givalos; Ioannis Vassilopoulos; K Ventouri; Artemis Tsenga; Aristotelis Bamias; Meletios A Dimopoulos; Emmanuel Agapitos; Efstratios Patsouris
Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications.
British journal of cancer 2007;97(8):1124-34.
2007: Efstathios Kastritis; Athanasios Anagnostopoulos; Maria Roussou; Savvas T Toumanidis; Constantinos Pamboukas; Magdalini Migkou; Anna Tassidou; Irini Xilouri; Souzana Delibasi; Erasmia Psimenou; Sofia Mellou; Evangelos Terpos; John N Nanas; Meletios A Dimopoulos
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone.
Haematologica 2007;92(10):1351-8.
2007: Theofanis Economopoulos; Amanda Psyrri; Meletios A Dimopoulos; Anna Kalogera-Fountzila; N Pavlidis; Costas Tsatalas; Costas Nikolaides; Sofia Mellou; Nikolaos Xiros; George Fountzilas
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group.
Cancer journal (Sudbury, Mass.) 2007;13(5):327-34.
2007: Evangelos Terpos; Meletios A Dimopoulos; O Sezer
The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma.
Leukemia 2007;21(9):1875-84.
2007: Evangelos Terpos; Orhan Sezer; Peter Croucher; Meletios A Dimopoulos
Myeloma bone disease and proteasome inhibition therapies.
Blood 2007;110(4):1098-104.
2007: Konstantinos Zervas; Dimitra Mihou; Eirini Katodritou; Anastasia Pouli; C H Mitsouli; Athanasios Anagnostopoulos; Souzana Delibasi; Marie-Christine Kyrtsonis; Nikolaos Anagnostopoulos; Evangelos Terpos; Panagiotis Zikos; Alice Maniatis; Meletios A Dimopoulos
VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek Myeloma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1369-75.
2007: Meletios A Dimopoulos; Athanasios Anagnostopoulos; Marie-Christine Kyrtsonis; Konstantinos Zervas; Costas Tsatalas; Garyfallia Kokkinis; Panagiotis Repoussis; Argyris Symeonidis; Souzana Delimpasi; Eirini Katodritou; Elisavet-Christine Vervessou; Evridiki Michali; Anastasia Pouli; Dimitra Gika; Amalia Vassou; Evangelos Terpos; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Gerassimos A Pangalis
Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3344-9.
2007: Aristotelis Bamias; Marinos L Tsiatas; E Kafantari; C Liakou; Alexandros Rodolakis; Zannis Voulgaris; George Vlahos; Theoharis Papageorgiou; Ourania E Tsitsilonis; Christina Bamia; George V Papatheodoridis; Ek Politi; Athanasios Archimandritis; Aris Antsaklis; Meletios A Dimopoulos
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
Gynecologic oncology 2007;106(1):75-81.
2007: Athanasios Anagnostopoulos; Vangelis Eleftherakis-Papaiakovou; Efstathios Kastritis; Konstantinos Tsionos; Aristotelis Bamias; John Meletis; Meletios A Dimopoulos; Evangelos Terpos
Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
British journal of haematology 2007;137(6):560-8.
2007: Meletios A Dimopoulos; Athanasios Anagnostopoulos
Treatment of Waldenstrom's Macroglobulinemia.
Current treatment options in oncology 2007;8(2):144-53.
2007: Efstathios Kastritis; Athanasios Anagnostopoulos; Maria Roussou; Dimitra Gika; Charis Matsouka; Despina Barmparousi; Irini Grapsa; Erasmia Psimenou; Aristotelis Bamias; Meletios A Dimopoulos
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents.
Haematologica 2007;92(4):546-9.
2007: Maria Roussou; Athanasios Anagnostopoulos; Efstathios Kastritis; Charis Matsouka; Despina Barmparousi; Vassiliki Koutsoukou; Meletios A Dimopoulos
Pulsed cyclophosphamide, thalidomide and dexamethasone regimen for previously treated patients with multiple myeloma: long term follow up and disease control after subsequent treatments.
Leukemia & lymphoma 2007;48(4):754-8.
2007: Amanda Psyrri; Panteleimon Kountourakis; Ziwei Yu; C Papadimitriou; Sonia Markakis; Robert L Camp; Theofanis Economopoulos; Meletios A Dimopoulos
Analysis of p53 protein expression levels on ovarian cancer tissue microarray using automated quantitative analysis elucidates prognostic patient subsets.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):709-15.
2007: Efstathios Kastritis; Meletios A Dimopoulos
The evolving role of lenalidomide in the treatment of hematologic malignancies.
Expert opinion on pharmacotherapy 2007;8(4):497-509.
2007: George Bozas; Aristotelis Bamias; Vassiliki Koutsoukou; Eleni Efstathiou; Dimitra Gika; Christos A Papadimitriou; Meletios A Dimopoulos
Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma.
Gynecologic oncology 2007;104(3):580-5.
2007: Paris A Kosmidis; Meletios A Dimopoulos; Konstantinos Syrigos; Costas Nicolaides; Gerasimos Aravantinos; Ioannis Boukovinas; Dimitrios Pectasides; George Fountzilas; Dimitrios Bafaloukos; Christos Bacoyiannis; Haralabos P Kalofonos
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(2):135-40.
2007: Vagelis Eleutherakis-Papaiakovou; Aristotelis Bamias; Dimitra Gika; A Simeonidis; Anastasia Pouli; Athanasios Anagnostopoulos; Evridiki Michali; Theofanis Economopoulos; Konstantinos Zervas; Meletios A Dimopoulos
Renal failure in multiple myeloma: incidence, correlations, and prognostic significance.
Leukemia & lymphoma 2007;48(2):337-41.
2007: Efstathios Kastritis; Aristotelis Bamias; George Bozas; Vassiliki Koutsoukou; Zannis Voulgaris; George Vlahos; Alexandros Rodolakis; Dimitra Gika; Christos Papadimitriou; Meletios A Dimopoulos
The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy.
Gynecologic oncology 2007;104(2):372-6.
2007: Aristotelis Bamias; George Lainakis; Efstathios Kastritis; Nikos Antoniou; Gerassimos Alivizatos; Andreas Koureas; Michael Chrisofos; Andreas Skolarikos; Evangelos Karayiotis; Meletios A Dimopoulos
Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment.
Oncology 2007;73(5-6):290-7.
2007: Christos A Papadimitriou; Markela P Zorzou; Sophia Markaki; Alexandros Rodolakis; Zannis Voulgaris; George Bozas; Efstathios Kastritis; Aristotelis Bamias; Dimitra Gika; Meletios A Dimopoulos
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience.
European journal of gynaecological oncology 2007;28(2):109-16.
2007: Giannis Mountzios; Meletios A Dimopoulos; Aristotelis Bamias; George Papadopoulos; Efstathios Kastritis; Konstantinos Syrigos; George Pavlakis; Evangelos Terpos
Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Acta oncologica (Stockholm, Sweden) 2007;46(2):221-9.
2007: Eleni Efstathiou; Meletios A Dimopoulos; George Bozas; Efstathios Kastritis; Lia A Moulopoulos; Alexandros Rodolakis; George Vlahos; Dimitra Gika; Christos Papadimitriou; Aristotelis Bamias
Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome.
Anticancer research 2007;27(1B):611-7.
2007: Spyros Milingos; Athanasios Protopapas; Christos Papadimitriou; Alexandros Rodolakis; George Kallipolitis; Nikolaos Skartados; Sophia Markaki; Meletios A Dimopoulos; Aris Antsaklis
Laparoscopy in the evaluation of women with unexplained ascites: an invaluable diagnostic tool.
Journal of minimally invasive gynecology 2007;14(1):43-8.
2006: Evangelos Terpos; Deborah J Heath; Amin Rahemtulla; Konstantinos Zervas; Andrew Chantry; Athanasios Anagnostopoulos; Anastasia Pouli; Eirini Katodritou; Evgenia Verrou; Elisavet-Christine Vervessou; Meletios A Dimopoulos; Peter I Croucher
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.
British journal of haematology 2006;135(5):688-92.
2006: Aristotelis Bamias; Ziwei Yu; Paul Weinberger; Sonia Markakis; Diane Kowalski; Robert L Camp; David L Rimm; Meletios A Dimopoulos; Amanda Psyrri
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1797-802.
2006: Athanasios Anagnostopoulos; Konstantinos Zervas; Marie-Christine Kyrtsonis; Argyris Symeonidis; Dimitra Gika; Konstantinos L Bourantas; Athanasios Zomas; Nikolaos Anagnostopoulos; Gerassimos A Pangalis; Meletios A Dimopoulos
Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment.
Clinical lymphoma & myeloma 2006;7(3):205-9.
2006: Meletios A Dimopoulos; Efstathios Kastritis
Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?
Leukemia & lymphoma 2006;47(11):2271-2.
2006: Lida Kostadima; George Pentheroudakis; George Fountzilas; Meletios A Dimopoulos; Dimitrios Pectasides; Helen Gogas; Udo Stropp; Christos Christodoulou; Epaminondas Samantas; Ralph Wirtz; Guido Hennig; Dimitrios Bafaloukos; P Arapantoni; Haralambos Kalofonos; Pavlos Papakostas; Theofanis Economopoulos; Aristotelis Bamias; Nicholas Pavlidis
Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival.
Breast cancer research and treatment 2006;100(2):161-7.
2006: George Papaxoinis; Sotirios Papageorgiou; DEMETRA RONTOGIANNI; Vassiliki Kaloutsi; George Fountzilas; Nicholas Pavlidis; Meletios A Dimopoulos; Costas Tsatalas; Nikolaos Xiros; Theofanis Economopoulos
Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG).
Leukemia & lymphoma 2006;47(10):2140-6.
2006: Marianna Politou; Deborah J Heath; Amin Rahemtulla; Richard Szydlo; Athanasios Anagnostopoulos; Meletios A Dimopoulos; Peter I Croucher; Evangelos Terpos
Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation.
International journal of cancer. Journal international du cancer 2006;119(7):1728-31.
2006: John Koutsikos; Vassiliki Grigoraki; Theodoros Athanasoulis; Antigoni Velidaki; Charalampos Mamoulakis; Athanasios Zomas; Nikos Anagnostopoulos; Evangelos Georgiou; Meletios A Dimopoulos; Cherry Zerva
Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System.
Hellenic journal of nuclear medicine 2006;9(3):177-80.
2006: Efstathios Kastritis; Meletios A Dimopoulos; Nikolaos Antoniou; Charalambos Deliveliotis; Michael Chrisofos; Andreas Skolarikos; Dimitra Gika; Aristotelis Bamias
The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapy.
Anticancer research 2006;26(5B):3865-9.
2006: Meletios A Dimopoulos; Efstathios Kastritis; Athanasios Anagnostopoulos
Hematological malignancies: myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 10():x137-43.
2006: VASSILIS SOULIOTIS; Meletios A Dimopoulos; Hara G Episkopou; Soterios A Kyrtopoulos; Petros P Sfikakis
Preferential in vivo DNA repair of melphalan-induced damage in human genes is greatly affected by the local chromatin structure.
DNA repair 2006;5(8):972-85.
2006: Meletios A Dimopoulos; Anastasia Pouli; Athanasios Anagnostopoulos; Panagiotis Repoussis; Argyris Symeonidis; Evangelos Terpos; Sosana Delimbasi; Friderikos Tsolakis; Theofanis Economopoulos; Constantinos Zervas
Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis.
Leukemia & lymphoma 2006;47(8):1553-6.
2006: Dimitrios Pectasides; George Fountzilas; Gerasimos Aravantinos; Charalambos Kalofonos; Helen Efstathiou; Dimitrios Farmakis; Dimosthenis Skarlos; Nicholas Pavlidis; Theofanis Economopoulos; Meletios A Dimopoulos
Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2006;102(2):285-91.
2006: Efstathios Kastritis; Evangelos Terpos; Athanasios Anagnostopoulos; Irini Xilouri; Meletios A Dimopoulos
Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support.
Clinical lymphoma & myeloma 2006;7(1):73-6.
2006: Meletios A Dimopoulos; Efstathios Kastritis; Athanasios Anagnostopoulos; Ioannis Melakopoulos; Dimitra Gika; Lia A Moulopoulos; Christina Bamia; Evangelos Terpos; Konstantinos Tsionos; Aristotelis Bamias
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
Haematologica 2006;91(7):968-71.
2006: Efstathios Kastritis; Lia A Moulopoulos; Ek Politi; Evagelos Kostis; George Pissakas; Meletios A Dimopoulos; Aristotelis Bamias
Intramedullary spinal cord and leptomeningeal metastases in a patient with carcinoma of the uterine cervix.
Gynecologic oncology 2006;102(1):124-7.
2006: Meletios A Dimopoulos
Treatment of AL amyloidosis with high dose therapy and autologous stem cell transplantation.
Leukemia & lymphoma 2006;47(6):963-4.
2006: Amanda Psyrri; Ziwei Yu; Aristotelis Bamias; Paul Weinberger; Sonia Markakis; Diane Kowalski; Robert L Camp; David L Rimm; Meletios A Dimopoulos
Evaluation of the prognostic value of cellular inhibitor of apoptosis protein in epithelial ovarian cancer using automated quantitative protein analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(6):1179-83.
2006: Efstathios Kastritis; Eleni Efstathiou; Dimitra Gika; George Bozas; Vassiliki Koutsoukou; Christos Papadimitriou; George Pissakas; Meletios A Dimopoulos; Aristotelis Bamias
Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):994-9.
2006: Constantinos Kilidireas; Athanasios Anagnostopoulos; Nikos Karandreas; Lefki Mouselimi; Meletios A Dimopoulos
Rituximab therapy in monoclonal IgM-related neuropathies.
Leukemia & lymphoma 2006;47(5):859-64.
2006: Evangelos Terpos; Vangelis Eleutherakis-Papaiakovou; Meletios A Dimopoulos
Clinical implications of chromosomal abnormalities in multiple myeloma.
Leukemia & lymphoma 2006;47(5):803-14.
2006: Evangelos Terpos; Athanasios Anagnostopoulos; Efstathios Kastritis; Aristotelis Bamias; Konstantinos Tsionos; Meletios A Dimopoulos
Abnormal bone remodelling and increased levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) in Waldenström macroglobulinaemia.
British journal of haematology 2006;133(3):301-4.
2006: Steve P Treon; Morie A Gertz; Meletios A Dimopoulos; Athanasios Anagnostopoulos; Joan Blade; Andrew R Branagan; Ramon Garcia-Sanz; Stephen Johnson; Eva Kimby; Veronique Leblond; Jean-Paul Fermand; David G Maloney; Giampaolo Merlini; Pierre Morel; Enrica Morra; Gwen Nichols; Enrique M Ocio; Roger Owen; lee stone
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
Blood 2006;107(9):3442-6.
2006: Ioannis Kostopoulos; Petroula Arapantoni-Dadioti; Helen Gogas; Savvas Papadopoulos; Vassiliki Malamou-Mitsi; Chrisoula D Scopa; Sophia Markaki; Evangelia Karagianni; Vassiliki Kyriakou; Anastasia Margariti; Elisavet Kyrkou; Kitty Pavlakis; Thomas Zaramboukas; Anna Skordalaki; Antonia Bourli; Christos Markopoulos; Dimitrios Pectasides; Meletios A Dimopoulos; Dimosthenis Skarlos; George Fountzilas
Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Breast cancer research and treatment 2006;96(3):251-61.
2006: Aristotelis Bamias; I Tiliakos; M-D Karali; Meletios A Dimopoulos
Systemic chemotherapy in inoperable or metastatic bladder cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):553-61.
2006: George Bozas; Anna Tassidou; Lia A Moulopoulos; Constantinos Constandinidis; Aristotelis Bamias; Meletios A Dimopoulos
Non-Hodgkin's lymphoma of the renal pelvis.
Clinical lymphoma & myeloma 2006;6(5):404-6.
2006: Eva Kimby; Steve P Treon; Athanasios Anagnostopoulos; Meletios A Dimopoulos; Ramon Garcia-Sanz; Morie A Gertz; Stephen Johnson; Veronique LeBlond; Jean-Paul Fermand; David G Maloney; Giampaolo Merlini; Pierre Morel; Enrica Morra; Gwen Nichols; Enrique M Ocio; Roger Owen; Marvin Stone; Joan Bladé
Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia.
Clinical lymphoma & myeloma 2006;6(5):380-3.
2006: Meletios A Dimopoulos; Athanasios Anagnostopoulos; Evangelos Terpos; Panagiotis Repoussis; Athanasios Zomas; Eirini Katodritou; Marie-Christine Kyrtsonis; Souzana Delibasi; Amalia Vassou; Anastasia Pouli; Konstantinos Zervas; Nikolaos Anagnostopoulos; Alice Maniatis
Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.
Haematologica 2006;91(2):252-4.
2006: George Bozas; Dimitra Anagnostou; Anna Tassidou; Lia A Moulopoulos; Aristotelis Bamias; Meletios A Dimopoulos
Extranodal non-Hodgkin's lymphoma presenting as an abdominal wall mass. A case report and review of the literature.
Leukemia & lymphoma 2006;47(2):329-32.
2006: Aristotelis Bamias; Lia A Moulopoulos; Angelos Koutras; Gerasimos Aravantinos; George Fountzilas; Dimitrios Pectasides; Efstathios Kastritis; Dimitra Gika; Dimosthenis Skarlos; Helena Linardou; Haralabos P Kalofonos; Meletios A Dimopoulos
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
Cancer 2006;106(2):297-303.
2006: Giannis Mountzios; George Pavlakis; Evangelos Terpos; George H Sakorafas; Kyriakos Revelos; Aristotelis Bamias; Nikolaos Nikolaou; Pantelis Papasavas; Jean-Charles Soria; Meletios A Dimopoulos
Concurrent development of testicular seminoma and choriocarcinoma of the superior mediastinum, presented as cervical mass: a case report and implications about pathogenesis of germ-cell tumours.
BMC clinical pathology 2006;6():8.
2006: Aristotelis Bamias; Christos Papadimitriou; Eleni Efstathiou; Alexandros Rodolakis; George Vlahos; Zannis Voulgaris; George Bozas; George Fountzilas; Gerasimos Aravantinos; Evangelia Razis; Dimitra Gika; Meletios A Dimopoulos
Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
BMC cancer 2006;6():228.
2006: George Bozas; Meletios A Dimopoulos; Efstathios Kastritis; Eleni Efstathiou; Vassiliki Koutsoukou; Alexandros Rodolakis; George Vlahos; Zannis Voulgaris; Theoharis Papageorgiou; Dimitra Gika; Christos Papadimitriou; Aristotelis Bamias
Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experience.
Oncology 2006;70(4):265-72.
2006: Aristotelis Bamias; Meletios A Dimopoulos
Inhibition of angiogenesis: common theme for cancer and atheromatosis?
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2006;47(1):11-2.
2005: Amanda Psyrri; Mohamad Kassar; Ziwei Yu; Aristotelis Bamias; Paul Weinberger; Sonia Markakis; Diane Kowalski; Robert L Camp; David L Rimm; Meletios A Dimopoulos
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8637-43.
2005: Aristotelis Bamias; Meletios A Dimopoulos
Neoadjuvant chemotherapy in invasive bladder cancer.
Expert review of anticancer therapy 2005;5(6):993-1000.
2005: Meletios A Dimopoulos; Athanasios Anagnostopoulos; Marie-Christine Kyrtsonis; Efstathios Castritis; Athanasios Bitsaktsis; Gerassimos A Pangalis
Treatment of relapsed or refractory Waldenström's macroglobulinemia with bortezomib.
Haematologica 2005;90(12):1655-8.
2005: Meletios A Dimopoulos
Tandem autologous stem cell transplantation for multiple myeloma: is it applicable and effective outside clinical trials?
Haematologica 2005;90(12):1588.
2005: Amanda Psyrri; Aristotelis Bamias; Ziwei Yu; Paul Weinberger; Mohamad Kassar; Sonia Markakis; Diane Kowalski; Eleni Efstathiou; Robert L Camp; David L Rimm; Meletios A Dimopoulos
Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8384-90.
2005: Aristotelis Bamias; Efstathios Kastritis; Christina Bamia; Lia A Moulopoulos; Ioannis Melakopoulos; George Bozas; Vassiliki Koutsoukou; Dimitra Gika; Athanasios Anagnostopoulos; Christos Papadimitriou; Evangelos Terpos; Meletios A Dimopoulos
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8580-7.
2005: Athanasios Anagnostopoulos; Dimitra Gika; Argyris Symeonidis; Konstantinos Zervas; Anastasia Pouli; Panagiotis Repoussis; Vassiliki Grigoraki; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Alice Maniatis; Meletios A Dimopoulos
Multiple myeloma in elderly patients: prognostic factors and outcome.
European journal of haematology 2005;75(5):370-5.
2005: Lia A Moulopoulos; Dimitra Gika; Athanasios Anagnostopoulos; Kay Delasalle; Donna Weber; Raymond Alexanian; Meletios A Dimopoulos
Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1824-8.
2005: Evangelos Terpos; Dimitra Mihou; Richard Szydlo; K Tsimirika; Christos Karkantaris; Marianna Politou; Ersi Voskaridou; Amin Rahemtulla; Meletios A Dimopoulos; Konstantinos Zervas
The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio.
Leukemia 2005;19(11):1969-76.
2005: Efstathios Kastritis; Aristotelis Bamias; Eleni Efstathiou; Dimitra Gika; George Bozas; P Zorzou; Kyrillos Sarris; Christos Papadimitriou; Meletios A Dimopoulos
The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
Gynecologic oncology 2005;99(2):376-82.
2005: Theofanis Economopoulos; Sotirios Papageorgiou; DEMETRA RONTOGIANNI; Vassiliki Kaloutsi; George Fountzilas; Costas Tsatalas; Nicholas Pavlidis; Dimitrios Pectasides; Efstathios Papageorgiou; Meletios A Dimopoulos
Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group study.
The oncologist 2005;10(9):734-8.
2005: Dimitrios Pectasides; Gerasimos Aravantinos; George Fountzilas; Charalambos Kalofonos; Eleni Efstathiou; Maria Karina; Nicholas Pavlidis; Dimitrios Farmakis; Theofanis Economopoulos; Meletios A Dimopoulos
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
Anticancer research 2005;25(5):3553-8.
2005: Efstathios Papageorgiou; Panagiotis Tsirigotis; Meletios A Dimopoulos; Nicholas Pavlidis; George Fountzilas; Sotirios Papageorgiou; Theofanis Economopoulos
Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group.
European journal of haematology 2005;75(2):124-9.
2005: Evangelos Terpos; Meletios A Dimopoulos
Myeloma bone disease: pathophysiology and management.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1223-31.
2005: Dimosthenis V Skarlos; Haralabos P Kalofonos; George Fountzilas; Meletios A Dimopoulos; Nicholas Pavlidis; Evangelia Razis; Theofanis Economopoulos; Dimitrios Pectasides; Helen Gogas; Paris A Kosmidis; Dimitrios Bafaloukos; George Klouvas; George Kyratzis; Gerasimos Aravantinos
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.
Anticancer research 2005;25(4):3103-8.
2005: Gerasimos Aravantinos; George Fountzilas; Paris A Kosmidis; Meletios A Dimopoulos; George P Stathopoulos; Nicholas Pavlidis; Dimitrios Bafaloukos; Christos Papadimitriou; S Karpathios; Vassilis Georgoulias; Pavlos Papakostas; Haralabos P Kalofonos; E Grimani; Dimosthenis V Skarlos
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1116-22.
2005: Meletios A Dimopoulos; VASSILIS SOULIOTIS; Athanasios Anagnostopoulos; Christos Papadimitriou; Petros P Sfikakis
Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4381-9.
2005: Georgios Chamilos; Aristotelis Bamias; Eleni Efstathiou; Pagona M Zorzou; Efstathios Kastritis; Evagelos Kostis; Christos Papadimitriou; Meletios A Dimopoulos
Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
Cancer 2005;103(12):2629-35.
2005: Andreas Skolarikos; Gerasimos Alivizatos; Aristotelis Bamias; Dionisios Mitropoulos; Nikolaos Ferakis; Charalambos Deliveliotis; Meletios A Dimopoulos
Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
International journal of urology : official journal of the Japanese Urological Association 2005;12(6):563-9.
2005: Evangelos Terpos; Amin Rahemtulla; Meletios A Dimopoulos
Current treatment options for myeloma.
Expert opinion on pharmacotherapy 2005;6(7):1127-42.
2005: Petros P Sfikakis; G M Gourgoulis; L A Moulopoulos; George Kouvatseas; A N Theofilopoulos; Meletios A Dimopoulos
Age-related thymic activity in adults following chemotherapy-induced lymphopenia.
European journal of clinical investigation 2005;35(6):380-7.
2005: John Koutsikos; Theodoros Athanasoulis; Athanasios Anagnostopoulos; Antigoni Velidaki; Marianthi Passadi; Meletios A Dimopoulos; Cherry Zerva
Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):978-82.
2005: Haralabos P Kalofonos; Gerasimos Aravantinos; Paris A Kosmidis; Pavlos Papakostas; Theofanis Economopoulos; Meletios A Dimopoulos; Dimosthenis Skarlos; Aristotelis Bamias; Dimitrios Pectasides; S Chalkidou; Maria Karina; Angelos Koutras; Epaminondas Samantas; Christos Bacoyiannis; Georgios Fotios Samelis; George Basdanis; Fotis Kalfarentzos; George Fountzilas
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(6):869-77.
2005: Dimitrios Pectasides; George Fountzilas; Gerasimos Aravantinos; Haralabos P Kalofonos; Eleni Efstathiou; Emmanuel Salamalekis; Dimitrios Farmakis; Dimosthenis Skarlos; Evangelos Briasoulis; Theofanis Economopoulos; Meletios A Dimopoulos
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2005;97(2):436-41.
2005: Meletios A Dimopoulos; Athanasios Anagnostopoulos; Constantinos Zervas; Marie-Christine Kyrtsonis; Athanasios Zomas; Constantinos Bourantas; Nikolaos Anagnostopoulos; Gerassimos A Pangalis
Predictive factors for response to rituximab in Waldenstrom's macroglobulinemia.
Clinical lymphoma 2005;5(4):270-2.
2005: Meletios A Dimopoulos; Robert A Kyle; Athanasios Anagnostopoulos; Steve P Treon
Diagnosis and management of Waldenstrom's macroglobulinemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1564-77.
2005: Markela P Zorzou; Eleni Efstathiou; Eleni Galani; George Bozas; Efstathios Kastritis; Christos Papadimitriou; Meletios A Dimopoulos; Aristotelis Bamias
Carboplatin hypersensitivity reactions: a single institution experience.
Journal of chemotherapy (Florence, Italy) 2005;17(1):104-10.
2005: Aristotelis Bamias; Eleni Efstathiou; Lia A Moulopoulos; Dimitra Gika; George Hamilos; Markela P Zorzou; C Kakoyiannis; Efstathios Kastritis; George Bozas; Christos Papadimitriou; Meletios A Dimopoulos
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):307-13.
2005: Evangelia Razis; Dimosthenis Skarlos; Evangelos Briasoulis; Meletios A Dimopoulos; George Fountzilas; S Lambropoulos; Sotiris K Rigatos; P Kopterides; H Efstathiou; Eleftheria Tzamakou; Chris N Bakoyannis; Dimitrios Pectasides; Thomas Makatsoris; G Varthalitis; Savvas Papadopoulos; Paris A Kosmidis
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program.
Anti-cancer drugs 2005;16(2):191-8.
2005: George Bozas; Aristotelis Bamias; Efstathios Kastritis; Alexandros Rodolakis; George Vlahos; Christos A Papadimitriou; Sophia Markaki; Meletios A Dimopoulos
Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus.
European journal of gynaecological oncology 2005;26(6):627-31.
2005: Aristotelis Bamias; Eleni Efstathiou; M Vassilakopoulou; Vassiliki Koutsoukou; Christos Papadimitriou; Alexandros Rodolakis; Dimitrios Mitsibounas; George Vlahos; Meletios A Dimopoulos
Late relapse of epithelial ovarian cancer: a single institution experience.
European journal of gynaecological oncology 2005;26(4):439-42.
2005: Meletios A Dimopoulos; Athanasios Anagnostopoulos
Waldenström's macroglobulinemia.
Best practice & research. Clinical haematology 2005;18(4):747-65.
2005: Theofanis Economopoulos; Sotirios Papageorgiou; Meletios A Dimopoulos; Nicholas Pavlidis; Costas Tsatalas; Argyris Symeonidis; A Foudoulakis; Dimitrios Pectasides; DEMETRA RONTOGIANNI; E Rizos; Panagiota Chalkia; A Anagnostopoulos; Maria Melachrinou; Efstathios Papageorgiou; George Fountzilas
Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Acta haematologica 2005;113(2):97-103.
2005: Aristotelis Bamias; Meletios A Dimopoulos
Thalidomide and immunomodulatory drugs in the treatment of cancer.
Expert opinion on investigational drugs 2005;14(1):45-55.
2005: Eleni Efstathiou; George Bozas; Athanasios Kostakopoulos; Efstathios Kastritis; Charalambos Deliveliotis; Nikolaos Antoniou; Dimosthenis Skarlos; Christos Papadimitriou; Meletios A Dimopoulos; Aristotelis Bamias
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Urology 2005;65(1):126-30.
2005: Meletios A Dimopoulos; Giampaolo Merlini; Veronique Leblond; Athanasios Anagnostopoulos; Raymond Alexanian
How we treat Waldenström's macroglobulinemia.
Haematologica 2005;90(1):117-25.
2005: Eleni Galani; Christos Alamanis; Meletios A Dimopoulos
Familial female and male germ cell cancer. A new syndrome?
Gynecologic oncology 2005;96(1):254-5.
2005: Markela P Zorzou; Sophia Markaki; Alexandros Rodolakis; Efstathios Kastritis; George Bozas; Meletios A Dimopoulos; Christos A Papadimitriou
Clinicopathological features of ovarian carcinosarcomas: a single institution experience.
Gynecologic oncology 2005;96(1):136-42.
2004: Meletios A Dimopoulos; Christos Papadimitriou; George Hamilos; Eleni Efstathiou; George Vlahos; Alexandros Rodolakis; Gerasimos Aravantinos; Haralambos Kalofonos; Charalambos Kouroussis; Dimitra Gika; Dimosthenis Skarlos; Aristotelis Bamias
Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
Gynecologic oncology 2004;95(3):695-700.
2004: Athanasios Anagnostopoulos; Dimitra Gika; George Hamilos; Konstantinos Zervas; Athanasios Zomas; Anastasia Pouli; Markela P Zorzou; Efstathios Kastritis; Nikolaos Anagnostopoulos; Anna Tassidou; Dimitra Anagnostou; Meletios A Dimopoulos
Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: identification of prognostic factors.
Leukemia & lymphoma 2004;45(11):2275-9.
2004: Meletios A Dimopoulos; Vagelis Eleutherakis-Papaiakovou
Adverse effects of thalidomide administration in patients with neoplastic diseases.
The American journal of medicine 2004;117(7):508-15.
2004: Meletios A Dimopoulos; Raymond Alexanian; Dimitra Gika; Athanasios Anagnostopoulos; Constantinos Zervas; Athanasios Zomas; Marie-Christine Kyrtsonis; Nikolaos Anagnostopoulos; Gerassimos A Pangalis; Donna M Weber
Treatment of Waldenstrom's macroglobulinemia with rituximab: prognostic factors for response and progression.
Leukemia & lymphoma 2004;45(10):2057-61.
2004: George Fountzilas; Haralabos P Kalofonos; Urania Dafni; Christos Papadimitriou; Dimitrios Bafaloukos; Pavlos Papakostas; Anna Kalogera-Fountzila; Helen Gogas; Gerasimos Aravantinos; Lia A Moulopoulos; Theofanis Economopoulos; Dimitrios Pectasides; N Maniadakis; V Siafaka; Evangelos Briasoulis; Christos Christodoulou; Dimitrios Tsavdaridis; P Makrantonakis; Evangelia Razis; Paris A Kosmidis; Dimosthenis Skarlos; Meletios A Dimopoulos
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1517-26.
2004: Athanasios Anagnostopoulos; Eleni Galani; Dimitra Gika; Danai Sotou; Aikaterini Evangelopoulou; Meletios A Dimopoulos
Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
Annals of hematology 2004;83(10):658-60.
2004: Marianna Politou; Evangelos Terpos; Athanasios Anagnostopoulos; Richard Szydlo; Michael A Laffan; Mark Layton; Jane F Apperley; Meletios A Dimopoulos; Amin Rahemtulla
Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).
British journal of haematology 2004;126(5):686-9.
2004: Aristotelis Bamias; Charalambos Deliveliotis; Aristidis Karayiannis; Ioannis M Varkarakis; Iannis M Zervas; Dimitrios Pantazopoulos; Dimitra Gika; Meletios A Dimopoulos
Neoadjuvant chemotherapy with docetaxel and cisplatin in patients with high-risk resectable bladder carcinoma: long term results.
European urology 2004;46(3):344-50; discussion 350-1.
2004: Meletios A Dimopoulos; Dimitra Gika; Konstantinos Zervas; Marie-Christine Kyrtsonis; Argyris Symeonidis; Athanasios Anagnostopoulos; Konstantinos L Bourantas; Charis Matsouka; Gerassimos A Pangalis
The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia.
Leukemia & lymphoma 2004;45(9):1809-13.
2004: Vagelis Eleutherakis-Papaiakovou; Aristotelis Bamias; Meletios A Dimopoulos
Thalidomide in cancer medicine.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1151-60.
2004: Eleni Andreopoulou; Dimitrios Pectasides; Meletios A Dimopoulos; Costas Nikolaides; George Fountzilas; Serena Valsami; Theofanis Economopoulos; Helen Andreopoulou
Primary mediastinal large B-cell lymphoma: clinical study of a distinct clinical entity and treatment outcome in 20 patients: review of the literature.
American journal of clinical oncology 2004;27(3):312-6.
2004: Aristotelis Bamias; Charalambos Deliveliotis; George Fountzilas; Dimitra Gika; Athanasios Anagnostopoulos; Markela P Zorzou; Efstathios Kastritis; Constantinos Constantinides; Paris A Kosmidis; Meletios A Dimopoulos
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2150-4.
2004: Jim Janinis; George P Stathopoulos; Pavlos Nikolaidis; Haralabos P Kalofonos; Anna Kalogera-Fountzila; Epaminondas Samantas; Gerasimos Aravantinos; Athanassios Anagnostopoulos; Christos Tolis; Thomas Makatsoris; Sotiris K Rigatos; Dimitrios Bafaloukos; Meletios A Dimopoulos; John Daniilidis; George Fountzilas
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Anti-cancer drugs 2004;15(5):479-87.
2004: Aristotelis Bamias; Charalambos Deliveliotis; Gerasimos Aravantinos; Charalambos Kalofonos; Aristidis Karayiannis; Meletios A Dimopoulos
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced bladder cancer: a study by the Hellenic Cooperative Oncology Group.
The Journal of urology 2004;171(4):1467-70.
2004: Aristotelis Bamias; Gerasimos Aravantinos; Charalambos Deliveliotis; Dimitrios Bafaloukos; Charalambos Kalofonos; Nikolaos Xiros; Anastasios Zervas; Dionisios Mitropoulos; Epaminondas Samantas; Dimitrios Pectasides; Pavlos Papakostas; Dimitra Gika; Charalabos Kourousis; Angelos Koutras; Christos Papadimitriou; C Bamias; Paris A Kosmidis; Meletios A Dimopoulos
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):220-8.
2004: Christos A Papadimitriou; Sophia Markaki; John Siapkaras; George Vlachos; Eleni Efstathiou; Irene Grimani; George Hamilos; Markela P Zorzou; Meletios A Dimopoulos
Hormonal therapy with letrozole for relapsed epithelial ovarian cancer. Long-term results of a phase II study.
Oncology 2004;66(2):112-7.
2004: Athanasios Anagnostopoulos; George Hamilos; Markela P Zorzou; Vassiliki Grigoraki; Dimitra Anagnostou; Meletios A Dimopoulos
Discordant response or progression in patients with myeloma treated with thalidomide-based regimens.
Leukemia & lymphoma 2004;45(1):113-6.
2004: Meletios A Dimopoulos; George Hamilos; Athanasios Zomas; Dimitra Gika; Eleni Efstathiou; Vassiliki Grigoraki; Christos Poziopoulos; Irini Xilouri; Markela P Zorzou; Nikolaos Anagnostopoulos; Athanasios Anagnostopoulos
Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(2):112-7.
2004: Meletios A Dimopoulos; Christos Kiamouris; Dimitra Gika; Charalambos Deliveliotis; Aris Giannopoulos; Anastasios Zervas; Christos Alamanis; Constantinos Constantinidis; Michael Koutsilieris
Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study.
Urology 2004;63(1):120-5.
2004: Christos A Papadimitriou; George Fountzilas; Gerasimos Aravantinos; Charalambos Kalofonos; Lia A Moulopoulos; Evangelos Briassoulis; Dimitra Gika; Meletios A Dimopoulos
Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study.
Gynecologic oncology 2004;92(1):152-9.
2004: Konstantinos Zervas; Meletios A Dimopoulos; E Hatzicharissi; Athanasios Anagnostopoulos; Mary Papaioannou; Chrisanthi Mitsouli; P Panagiotidis; J Korantzis; Michalis Tzilianos; Alice Maniatis
Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(1):134-8.
2003: Meletios A Dimopoulos; Athanasios Anagnostopoulos; Donna Weber
Treatment of plasma cell dyscrasias with thalidomide and its derivatives.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4444-54.
2003: Meletios A Dimopoulos; Athanasios Anagnostopoulos
Thalidomide in relapsed/refractory multiple myeloma: pivotal trials conducted outside the United States.
Seminars in hematology 2003;40(4 Suppl 4):8-16.
2003: VASSILIS SOULIOTIS; Meletios A Dimopoulos; Petros P Sfikakis
Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4465-74.
2003: Theofanis Economopoulos; George Fountzilas; Meletios A Dimopoulos; Sotirios Papageorgiou; Nikolaos Xiros; Dimitris Kalantzis; John Dervenoulas; Sotirios Raptis
Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study.
European journal of haematology 2003;71(4):257-62.
2003: Theodoros Athanasoulis; John Koutsikos; L A Moulopoulos; Spyridon Tsiouris; Meletios A Dimopoulos; Cherry Zerva
Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy.
Clinical nuclear medicine 2003;28(8):631-5.
2003: Aristotelis Bamias; Maria Chorti; Charalambos Deliveliotis; Nikolaos Trakas; Andreas Skolarikos; B Protogerou; S Legaki; G Tsakalou; Nikolaos Tamvakis; Meletios A Dimopoulos
Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.
Urology 2003;62(2):368-73.
2003: Meletios A Dimopoulos; George Hamilos; Konstantinos Zervas; Argyris Symeonidis; George Kouvatseas; Paraskevi Roussou; Dimitra Gika; Themis Karmiris; Konstantinos L Bourantas; Athanasios Zomas; Chrisanthi Mitsouli; Irini Xilouri; Elisavet-Christine Vervessou; K Matsis; Nikolaos Anagnostopoulos; Theofanis Economopoulos
Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1299-305.
2003: Gerasimos Aravantinos; Dimitrios Bafaloukos; G Fountzilas; C Christodoulou; Christos Papadimitriou; Nicholas Pavlidis; H P Kalofonos; H Gogas; Paris A Kosmidis; Meletios A Dimopoulos
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1094-9.
2003: Meletios A Dimopoulos; Anastasia Pouli; Konstantinos Zervas; Vassiliki Grigoraki; Argyris Symeonidis; Panagiotis Repoussis; Chrisanthi Mitsouli; C Papanastasiou; Dimitris Margaritis; A Tokmaktsis; I Katodritou; Garoufalia Kokkini; Evangelos Terpos; N Vyniou; Michalis Tzilianos; A Chatzivassili; Marie-Christine Kyrtsonis; Panayiotis Panayiotidis; Alice Maniatis
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1039-44.
2003: John Lekakis; Meletios A Dimopoulos; Vassilios Prassopoulos; Myron Mavrikakis; Sophia Gerali; Nicos Sifakis; Theodoros Athanassoulis; Stamatios F Stamatelopoulos
Myocardial adrenergic denervation in patients with primary (AL) amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2003;10(2):117-20.
2003: Meletios A Dimopoulos; George Hamilos; Eleni Efstathiou; Ioannis Siapkaras; Charis Matsouka; Dimitra Gika; Vassiliki Grigoraki; Christos Papadimitriou; Dimitrios Mitsibounas; Nikolaos Anagnostopoulos
Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.
Leukemia & lymphoma 2003;44(6):993-6.
2003: Vagelis Eleutherakis-Papaiakovou; M Karali; I Kokkonouzis; I Tiliakos; Meletios A Dimopoulos
Bone marrow angiogenesis and progression in multiple myeloma: clinical significance and therapeutic approach.
Leukemia & lymphoma 2003;44(6):937-48.
2003: Georgios Fotios Samelis; Dimosthenis Skarlos; D Bafaloukos; Paris A Kosmidis; A Anagnostopoulos; Gerasimos Aravantinos; Meletios A Dimopoulos
The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Urology 2003;61(6):1211-5.
2003: Meletios A Dimopoulos; Costas Tsatalas; Athanasios Zomas; George Hamilos; Panayiotis Panayiotidis; Dimitris Margaritis; Charis Matsouka; Theofanis Economopoulos; Nikolaos Anagnostopoulos
Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone.
Seminars in oncology 2003;30(2):265-9.
2003: Donna M Weber; Meletios A Dimopoulos; Kay Delasalle; Kim Rankin; Maria Gavino; Raymond Alexanian
2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia.
Seminars in oncology 2003;30(2):243-7.
2003: Raymond Alexanian; Donna Weber; Kay Delasalle; Fernando Cabanillas; Meletios A Dimopoulos
Asymptomatic Waldenstrom's macroglobulinemia.
Seminars in oncology 2003;30(2):206-10.
2003: Roger G Owen; Steve P Treon; Ayad Al-Katib; Rafael Fonseca; Philip R Greipp; Mary L McMaster; Enrica Morra; Gerassimos A Pangalis; Jesús F San Miguel; Andrew R Branagan; Meletios A Dimopoulos
Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Seminars in oncology 2003;30(2):110-5.
2003: Steve P Treon; Meletios A Dimopoulos; Robert A Kyle
Defining Waldenstrom's macroglobulinemia.
Seminars in oncology 2003;30(2):107-9.
2003: Ourania Katopodis; Stamatis-Nick C Liossis; Vassilios Viglis; Anastasia Pouli; Meletios A Dimopoulos; Petros P Sfikakis
Expansion of CD8+ T cells that express low levels of the B cell-specific molecule CD20 in patients with multiple myeloma.
British journal of haematology 2003;120(3):478-81.
2003: Theofanis Economopoulos; George Fountzilas; Nicholas Pavlidis; Dimitris Kalantzis; Efstathios Papageorgiou; Christos Christodoulou; George Hamilos; Costas Nicolaides; Meletios A Dimopoulos
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(2):110-5.
2003: Meletios A Dimopoulos; Christos Papadimitriou; Athanasios Anagnostopoulos; Dimitrios Mitsibounas; Jean-Paul Fermand
High dose therapy with autologous stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrence.
Leukemia & lymphoma 2003;44(1):153-5.
2003: Lia A Moulopoulos; T G Maris; Nickolas Papanikolaou; G Panagi; Lambros Vlahos; Meletios A Dimopoulos
Detection of malignant bone marrow involvement with dynamic contrast-enhanced magnetic resonance imaging.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(1):152-8.
2002: Meletios A Dimopoulos; Constantinos Zervas; Athanasios Zomas; George Hamilos; Dimitra Gika; Eleni Efstathiou; Panayiotis Panayiotidis; Elisavet-Christine Vervessou; Nikolaos Anagnostopoulos; John Christakis
Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemia.
Clinical lymphoma 2002;3(3):163-6.
2002: Paris A Kosmidis; Nicolas Mylonakis; Costas Nicolaides; Charalabos Kalophonos; Epaminondas Samantas; John Boukovinas; George Fountzilas; Dimosthenis Skarlos; Theofanis Economopoulos; Dimitrios Tsavdaridis; Pavlos Papakostas; Christos Bacoyiannis; Meletios A Dimopoulos
Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3578-85.
2002: Athanasios Anagnostopoulos; A Evangelopoulou; Danai Sotou; Dimitra Gika; Dimitrios Mitsibounas; Meletios A Dimopoulos
Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Annals of hematology 2002;81(7):357-61.
2002: Meletios A Dimopoulos; George Hamilos
Solitary bone plasmacytoma and extramedullary plasmacytoma.
Current treatment options in oncology 2002;3(3):255-9.
2002: Meletios A Dimopoulos; Christos A Papadimitriou; Kyrillos Sarris; Gerasimos Aravantinos; Charalambos Kalofonos; Dimitra Gika; Georgios M Gourgoulis; Eleni Efstathiou; Dimosthenis Skarlos; Dimitrios Bafaloukos
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.
Gynecologic oncology 2002;85(3):476-82.
2002: Eleni Andreopoulou; Demetrios M Andreopoulos; Konstantinos Adamidis; A Fountzila-Kalogera; George Fountzilas; Meletios A Dimopoulos; Gerasimos Aravantinos; N Zamboglou; D Baltas; Nicholas Pavlidis
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer.
Anticancer research 2002;22(3):1903-8.
2002: Meletios A Dimopoulos; Constantinos Zervas; Athanasios Zomas; Christos Kiamouris; Nora Viniou; Vassiliki Grigoraki; Christos Karkantaris; Chrisanthi Mitsouli; Dimitra Gika; John Christakis; Nikolaos Anagnostopoulos
Treatment of Waldenström's macroglobulinemia with rituximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2327-33.
2002: Spyros Michopoulos; Kalliopi Petraki; Constantina D Petraki; Meletios A Dimopoulos
Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome.
Digestive diseases and sciences 2002;47(4):730-4.
2002: Theofanis Economopoulos; Meletios A Dimopoulos; Sofia Mellou; Nicholas Pavlidis; Epaminondas Samantas; Costas Nicolaides; Costas Tsatalas; A Papadopoulos; E Papageogriou; P Papasavvas; George Fountzilas
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
European journal of haematology 2002;68(3):135-43.
2002: Haralabos P Kalofonos; Costas Nicolaides; Epaminondas Samantas; Nicolas Mylonakis; Gerasimos Aravantinos; Meletios A Dimopoulos; Constantinos Gennatas; George Kouvatseas; Eleftherios Giannoulis; Christos Dervenis; George Basdanis; Nicholas Pavlidis; Ioannis Androulakis; George Fountzilas
A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
American journal of clinical oncology 2002;25(1):23-30.
2002: Ioanna Dimopoulou; Heleni Galani; Urania Dafni; Anastasia Samakovii; Charis Roussos; Meletios A Dimopoulos
A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
Cancer 2002;94(2):452-8.
2002: Christos Bacoyiannis; Meletios A Dimopoulos; Haralabos P Kalofonos; Costas Nicolaides; Gerasimos Aravantinos; Dimitrios Bafaloukos; Georgios Fotios Samelis; Adimchi Onyenadum; Christos Kiamouris; Dimosthenis Skarlos; Nicholas Pavlidis; A Triantafillidis; Paris A Kosmidis
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials.
Oncology 2002;63(2):130-8.
2002: Meletios A Dimopoulos; George Fountzilas; Efstathios Papageorgiou; Christos Kiamouris; George Mantzios; Athanasios Anagnostopoulos; Costas Nicolaides; Theofanis Economopoulos
Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group.
Leukemia & lymphoma 2002;43(1):111-4.
2001: Dimitrios Pectasides; Gerasimos Aravantinos; Haralambos Kalofonos; Christos Kiamouris; Dimitrios Bafaloukos; Nikolaos Xiros; Costas Nicolaides; A Visvikis; Meletios A Dimopoulos
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(10):1417-22.
2001: Christos A Papadimitriou; Charalambos Kouroussis; Lia A Moulopoulos; George Vlahos; Alexandros Rodolakis; Christos Kiamouris; Emmanuel Diakomanolis; Dimitra Gika; Stylianos Michalas; Meletios A Dimopoulos
Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer.
Cancer 2001;92(7):1856-63.
2001: Meletios A Dimopoulos; Athanasios Zomas; Nora Viniou; Vassiliki Grigoraki; Eleni Galani; Charis Matsouka; O Economou; Nikolaos Anagnostopoulos; Panayiotis Panayiotidis
Treatment of Waldenstrom's macroglobulinemia with thalidomide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(16):3596-601.
2001: Meletios A Dimopoulos; Konstantinos Zervas; George Kouvatseas; Eleni Galani; Vassiliki Grigoraki; Christos Kiamouris; Elisavet-Christine Vervessou; Epaminondas Samantas; Christos Papadimitriou; O Economou; Dimitra Gika; Panayiotis Panayiotidis; I Christakis; Nikolaos Anagnostopoulos
Thalidomide and dexamethasone combination for refractory multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(7):991-5.
2001: Raymond Alexanian; Donna Weber; Sergio Giralt; Meletios A Dimopoulos; Kay Delasalle; T Smith; Richard Champlin
Impact of complete remission with intensive therapy in patients with responsive multiple myeloma.
Bone marrow transplantation 2001;27(10):1037-43.
2001: Athanasios Anagnostopoulos; Meletios A Dimopoulos; Ana Aleman; Donna Weber; Raymond Alexanian; Richard Champlin; Sergio Giralt
High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia.
Bone marrow transplantation 2001;27(10):1027-9.
2001: George Fountzilas; Christos Papadimitriou; Urania Dafni; Dimitrios Bafaloukos; Dimosthenis Skarlos; Lia A Moulopoulos; Evangelia Razis; Haralabos P Kalofonos; Gerasimos Aravantinos; Evangelos Briassoulis; Pavlos Papakostas; K Abela; E Gogas; Paris A Kosmidis; Nicholas Pavlidis; Meletios A Dimopoulos
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2232-9.
2001: Avichai Shimoni; Terry L Smith; Ana Aleman; Donna Weber; Meletios A Dimopoulos; Paolo Anderlini; Borje Andersson; David F Claxton; Naoto T Ueno; Issa Khouri; Michele Donato; Martin Korbling; Raymond Alexanian; Richard Champlin; Sergio Giralt
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.
Bone marrow transplantation 2001;27(8):821-8.
2001: Stamatis-Nick C Liossis; Elena E Solomou; Meletios A Dimopoulos; Panayiotis Panayiotidis; MM Mavrikakis; Petros P Sfikakis
B-cell kinase lyn deficiency in patients with systemic lupus erythematosus.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2001;49(2):157-65.
2001: Evangelos Briasoulis; Eleni Andreopoulou; Christos Tolis; Eleni Bairaktari; Afroditi Katsaraki; Meletios A Dimopoulos; George Fountzilas; C Seferiadis; Nicholas Pavlidis
G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting.
Cancer 2001;91(5):909-17.
2001: Vassiliky D Petrocheilou-Paschou; H Prifti; Evagelos Kostis; Christos Papadimitriou; Meletios A Dimopoulos; Stamatios F Stamatelopoulos
Rhodotorula septicemia: case report and minireview.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;7(2):100-2.
2001: Meletios A Dimopoulos; Eleni Galani
Randomized trials of adjuvant and neoadjuvant chemotherapy in bladder cancer.
Seminars in urologic oncology 2001;19(1):59-65.
2001: Georgia Agiostratidou; I Sgouros; Eleni Galani; A Voulgari; Niki Chondrogianni; Epaminondas Samantas; Meletios A Dimopoulos; Dimosthenis Skarlos; Efstathios S Gonos
Correlation of in vitro cytotoxicity and clinical response to chemotherapy in ovarian and breast cancer patients.
Anticancer research 2001;21(1A):455-9.
2001: Konstantinos Zervas; Anastasia Pouli; B Gregoraki; Nikolaos Anagnostopoulos; Meletios A Dimopoulos; Konstantinos L Bourantas; Michalis Tzilianos; D Barbarousi; E Venetis; N Vyniou; Alice Maniatis
Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisone (VBMCP) and interferon-alpha with melphalan and prednisone (MP) and interferon-alpha (IFN-alpha) in patients with good-prognosis multiple myeloma: a prospective randomized study. Greek Myeloma Study Group.
European journal of haematology 2001;66(1):18-23.
2000: Raymond Alexanian; Donna Weber; Meletios A Dimopoulos; Kay Delasalle; T L Smith
Randomized trial of alpha-interferon or dexamethasone as maintenance treatment for multiple myeloma.
American journal of hematology 2000;65(3):204-9.
2000: Nikolaos G Kastrinakis; Vassilis G Gorgoulis; Periklis G Foukas; Meletios A Dimopoulos; Christos Kittas
Molecular aspects of multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1217-28.
2000: Christos A Papadimitriou; Lia A Moulopoulos; George Vlahos; Zannis Voulgaris; E Kiosses; Nicolaos Georgoulias; Dimitra Gika; Emmanuel Diakomanolis; Stylianos Michalas; Meletios A Dimopoulos
Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study.
Cancer 2000;89(7):1547-54.
2000: Meletios A Dimopoulos; Lia A Moulopoulos; Alice Maniatis; Raymond Alexanian
Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
Blood 2000;96(6):2037-44.
2000: Costas Nicolaides; Meletios A Dimopoulos; Epaminondas Samantas; Dimitrios Bafaloukos; Charalambos Kalofonos; George Fountzilas; Evangelia Razi; Paris A Kosmidis; Nicholas Pavlidis
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):873-5.
2000: Paris A Kosmidis; Nicolas Mylonakis; Dimosthenis Skarlos; Epaminondas Samantas; Meletios A Dimopoulos; C Papadimitriou; Charalabos Kalophonos; Nicholas Pavlidis; C Nikolaidis; C Papaconstantinou; George Fountzilas
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):799-805.
2000: Meletios A Dimopoulos; Christos A Papadimitriou; Vassilis Georgoulias; Lia A Moulopoulos; Gerasimos Aravantinos; Dimitra Gika; S Karpathios; Stamatios F Stamatelopoulos
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study.
Gynecologic oncology 2000;78(1):52-7.
2000: C Papadimitris; Maria Alevizaki; Dimitrios Pantazopoulos; Lydia Nakopoulou; Peter Athanassiades; Meletios A Dimopoulos
Cushing syndrome as the presenting feature of metastatic Leydig cell tumor of the testis.
Urology 2000;56(1):153.
2000: Athanasios Zomas; Nikolaos Anagnostopoulos; Meletios A Dimopoulos
Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent.
Bone marrow transplantation 2000;25(12):1319-20.
2000: Charalambos Kouroussis; George Samonis; Nikolaos Androulakis; John Souglakos; Argyro Voloudaki; Meletios A Dimopoulos; T Kotsakis; Stylianos Kakolyris; Kostas Kalbakis; Vassilis Georgoulias
Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases.
American journal of clinical oncology 2000;23(3):309-13.
2000: Gerasimos Aravantinos; Meletios A Dimopoulos; Paris A Kosmidis; Dimitrios Bafaloukos; Christos Papadimitriou; Christos Kiamouris; Nicholas Pavlidis; K Sikiotis; Pavlos Papakostas; Dimosthenis V Skarlos
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(5):607-12.
2000: Dimitrios Pectasides; Theofanis Economopoulos; George Kouvatseas; A Antoniou; Z Zoumbos; Gerasimos Aravantinos; Costas Tsatalas; A Halikia; Costas Nikolaides; Christos Kiamouris; E Pappa; Nicholas Pavlidis; Dimosthenis Skarlos; George Fountzilas; Meletios A Dimopoulos
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience.
Oncology 2000;58(4):286-92.
2000: Meletios A Dimopoulos; Lia A Moulopoulos; I Datseris; Donna Weber; Kay Delasalle; Dimitra Gika; Raymond Alexanian
Imaging of myeloma bone disease--implications for staging, prognosis and follow-up.
Acta oncologica (Stockholm, Sweden) 2000;39(7):823-7.
2000: Christos A Papadimitriou; Meletios A Dimopoulos; Vassili N Kouvelis; Evagelos Kostis; Violeta Kapsimali; D Contoyannis; Athanasios Anagnostopoulos; C Papadimitris; Christos Kiamouris; Dimitra Gika; John N Nanas; Peter Athanassiades; Stamatios F Stamatelopoulos
Non-cryopreserved peripheral blood progenitor cells collected by a single very large-volume leukapheresis: a simplified and effective procedure for support of high-dose chemotherapy.
Journal of clinical apheresis 2000;15(4):236-41.
2000: Meletios A Dimopoulos; Panayiotis Panayiotidis; Lia A Moulopoulos; Petros P Sfikakis; M Dalakas
Waldenström's macroglobulinemia: clinical features, complications, and management.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):214-26.
1999: Meletios A Dimopoulos; Eleni Galani; Charis Matsouka
Waldenström's macroglobulinemia.
Hematology/oncology clinics of North America 1999;13(6):1351-66.
1999: Meletios A Dimopoulos; Christos Kiamouris; Lia A Moulopoulos
Solitary plasmacytoma of bone and extramedullary plasmacytoma.
Hematology/oncology clinics of North America 1999;13(6):1249-57.
1999: Meletios A Dimopoulos; Chris N Bakoyannis; Vassilis Georgoulias; Christos Papadimitriou; Lia A Moulopoulos; Charalambos Deliveliotis; A Karayannis; Ioannis M Varkarakis; Gerasimos Aravantinos; Anastasios Zervas; Dimitrios Pantazopoulos; George Fountzilas; Aristotelis Bamias; Zacharias Kyriakakis; Athanasios Anagnostopoulos; Aris Giannopoulos; Paris A Kosmidis
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1385-8.
1999: Nikolaos Androulakis; Charalabos Kourousis; Meletios A Dimopoulos; Georgios Fotios Samelis; Stylianos Kakolyris; Nicolas Tsavaris; K Genatas; Gerasimos Aravantinos; Christos Papadimitriou; Spyros Karabekios; George P Stathopoulos; Vassilis Georgoulias
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1779-85.
1999: Lia A Moulopoulos; Meletios A Dimopoulos; Athina D Vourtsi; Athanasios Gouliamos; Lambros Vlahos
Bone lesions with soft-tissue mass: magnetic resonance imaging diagnosis of lymphomatous involvement of the bone marrow versus multiple myeloma and bone metastases.
Leukemia & lymphoma 1999;34(1-2):179-84.
1999: Vassilis Georgoulias; Charalambos Kouroussis; Nikolaos Androulakis; Stylianos Kakolyris; Meletios A Dimopoulos; Emmanuel Papadakis; Demosthenes Bouros; F Apostolopoulou; Christos Papadimitriou; Athina Agelidou; Kostas D Hatzakis; Kostas Kalbakis; Athanasios Kotsakis; Nikolaos Vardakis; J Vlachonicolis
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):914-20.
1999: Christos A Papadimitriou; Kyrillos Sarris; Lia A Moulopoulos; George Fountzilas; Athanasios Anagnostopoulos; Zannis Voulgaris; Dimitra Gika; Nicholaos Giannakoulis; Emmanuel Diakomanolis; Meletios A Dimopoulos
Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):761-6.
1999: C Papadimitris; Meletios A Dimopoulos; Evagelos Kostis; Christos Papadimitriou; Athanasios Anagnostopoulos; George Alexopoulos; Christos M Papamichael; Dimitra Gika; Dimitrios Mitsibounas; Stamatios F Stamatelopoulos
Outpatient treatment of neutropenic fever with oral antibiotics and granulocyte colony-stimulating factor.
Oncology 1999;57(2):127-30.
1998: Christos A Papadimitriou; Meletios A Dimopoulos; C Ampela; A Louvrou-Fertaki; Athanasios Anagnostopoulos; Peter Athanassiades; Stamatios F Stamatelopoulos; Antonios Keramopoulos
Sequential administration of doxorubicin and paclitaxel followed by cyclophosphamide, methotrexate and 5-fluorouracil combination (CMF) in women with metastatic breast cancer.
Oncology 1998;55(6):533-7.
1998: Meletios A Dimopoulos; Marianna Papadopoulou; Eleni Andreopoulou; Christos Papadimitriou; Nicholas Pavlidis; Gerasimos Aravantinos; A Aspropotamitis; A Anagnostopoulos; George Fountzilas; Stylianos Michalas; D Pectacides
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
Gynecologic oncology 1998;70(1):70-4.
1998: Meletios A Dimopoulos; Charalambos Deliveliotis; Lia A Moulopoulos; Christos Papadimitriou; Dionisios Mitropoulos; A Anagnostopoulos; Peter Athanassiades; Constantinos Dimopoulos
Treatment of patients with metastatic urothelial carcinoma and impaired renal function with single-agent docetaxel.
Urology 1998;52(1):56-60.
1998: Dimitrios Pantazopoulos; Petros Karakitsos; Abraham Pouliakis; A Iokim-Liossi; Meletios A Dimopoulos
Static cytometry and neural networks in the discrimination of lower urinary system lesions.
Urology 1998;51(6):946-50.
1998: Chu-Myong Seong; Kay Delasalle; Kimberly Hayes; Donna Weber; Meletios A Dimopoulos; J Swantkowski; Yang Huh; Armand B. Glassman; Richard Champlin; Raymond Alexanian
Prognostic value of cytogenetics in multiple myeloma.
British journal of haematology 1998;101(1):189-94.
1998: Meletios A Dimopoulos; Lia A Moulopoulos
Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1601-12.
1998: Petros P Sfikakis; Meletios A Dimopoulos; VASSILIS SOULIOTIS; Dionisios Charalambopoulos; MM Mavrikakis; Panayiotis Panayiotidis
Effects of 2-chlorodeoxyadenosine and gold sodium thiomalate on human bcl-2 gene expression.
Immunopharmacology and immunotoxicology 1998;20(1):63-77.
1998: James R Berenson; A Lichtenstein; L Porter; Meletios A Dimopoulos; R Bordoni; S George; Allan Lipton; A Keller; O Ballester; M Kovacs; H Blacklock; R Bell; Joe Simeone; Dirk Reitsma; M Heffernan; John Seaman; Robert D Knight
Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):593-602.
1998: George Fountzilas; A Athanassiades; V Papadimitriou; Meletios A Dimopoulos; Dimitrios Bafaloukos; Gerasimos Aravantinos; Costas Nicolaides; Haralambos Kalofonos; Pavlos Papakostas; Nikolaos Xiros; Evangelia Razi
Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.
Oncology (Williston Park, N.Y.) 1998;12(1 Suppl 1):45-8.
1997: Meletios A Dimopoulos; Evagelos Kostis; Athanasios Anagnostopoulos; M Dalezios; C Papadimitris; Christos Papadimitriou
Very late relapse of Hodgkin's disease after 24 years of complete remission.
Leukemia & lymphoma 1997;28(1-2):215-7.
1997: Meletios A Dimopoulos; Christos Panopoulos; Christina Bamia; Charalambos Deliveliotis; Gerasimos Alivizatos; Dimitrios Pantazopoulos; C Constantinidis; Athanasios Kostakopoulos; Ioannis Kastriotis; Anastasios Zervas; Gerasimos Aravantinos; Constantinos Dimopoulos
Oral estramustine and oral etoposide for hormone-refractory prostate cancer.
Urology 1997;50(5):754-8.
1997: John Lekakis; Meletios A Dimopoulos; John N Nanas; Vassilios Prassopoulos; N Agapitos; George Alexopoulos; L Palazis; P Kostamis; Stamatios F Stamatelopoulos; Spyridon D Moulopoulos
Antimyosin scintigraphy for detection of cardiac amyloidosis.
The American journal of cardiology 1997;80(7):963-5.
1997: Lia A Moulopoulos; Meletios A Dimopoulos
Magnetic resonance imaging of the bone marrow in hematologic malignancies.
Blood 1997;90(6):2127-47.
1997: Vassilis Georgoulias; Charalabos Kourousis; Nikolaos Androulakis; Stylianos Kakolyris; Meletios A Dimopoulos; Demosthenes Bouros; Christos Papadimitriou; Kostas D Hatzakis; P Heras; Kostas Kalbakis; T Kotsakis; Nikolaos Vardakis; N Meramveliotakis; Dora Hatzidaki
Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.
Seminars in oncology 1997;24(4 Suppl 14):S14-22-S14-25.
1997: Vassilis Georgoulias; Charalabos Kourousis; Stylianos Kakolyris; Nikolaos Androulakis; Meletios A Dimopoulos; Emmanuel Papadakis; T Kotsakis; Nikolaos Vardakis; Kostas Kalbakis; N Merambeliotakis; Dora Hatzidaki
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimen.
Seminars in oncology 1997;24(4 Suppl 12):S12-61-S12-66.
1997: Zacharias Kyriakakis; Meletios A Dimopoulos; Athanasios Kostakopoulos; Aristidis Karayiannis; Frank Sofras; Anastasios Zervas; Aris Giannopoulos; Constantinos Dimopoulos
Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
The Journal of urology 1997;158(2):408-11.
1997: Christos A Papadimitriou; Meletios A Dimopoulos; Nicholaos Giannakoulis; Kyrillos Sarris; G Vassilakopoulos; Thrassivoulos Akrivos; Zannis Voulgaris; George Vlahos; Emmanuel Diakomanolis; Stylianos Michalas
A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix.
Cancer 1997;79(12):2391-5.
1997: Andreas H Sarris; V Papadimitrakopoulou; Meletios A Dimopoulos; T Smith; WC Pugh; Chul Ha; Peter McLaughlin; David L Callender; J Cox; Fernando Cabanillas
Primary parotid lymphoma: the effect of International Prognostic Index on outcome.
Leukemia & lymphoma 1997;26(1-2):49-56.
1997: Donna M Weber; Meletios A Dimopoulos; L A Moulopoulos; Kay Delasalle; T Smith; Raymond Alexanian
Prognostic features of asymptomatic multiple myeloma.
British journal of haematology 1997;97(4):810-4.
1997: Meletios A Dimopoulos; M Theodorakis; Evagelos Kostis; C Papadimitris; Lia A Moulopoulos; Maria I Anastasiou-Nana
Treatment of Langerhans cell histiocytosis with 2 chlorodeoxyadenosine.
Leukemia & lymphoma 1997;25(1-2):187-9.
1997: C Papadimitris; Christos Papadimitriou; Nikos Kokolakis; Peter Athanassiades; Meletios A Dimopoulos
Late relapse of nonseminomatous germ cell tumor of the testis: successful treatment with salvage chemotherapy alone.
Urology 1997;49(3):469-70.
1997: Meletios A Dimopoulos; Danai D Daliani; WC Pugh; David M Gershenson; Fernando Cabanillas; Andreas H Sarris
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy.
Gynecologic oncology 1997;64(3):446-50.
1997: Meletios A Dimopoulos; Christos Papadimitriou; Constantinos Gennatas; Thrassivoulos Akrivos; George Vlahos; Zannis Voulgaris; E Diacomanolis; Peter Athanassiades; S Mihalas
Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelial ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(2):195-7.
1997: Sergio Giralt; Donna Weber; MI Colome; Meletios A Dimopoulos; RC Mehra; Koen van Besien; James L Gajewski; Borje Andersson; Issa Khouri; Donna Przepiorka; B von Wolff; Kay Delasalle; Martin Korbling; D Seong; Raymond Alexanian; Richard Champlin
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):667-73.
1997: Andreas H Sarris; Rajyalakshmi Luthra; V Papadimitracopoulou; M Waasdorp; Meletios A Dimopoulos; JA McBride; Fernando Cabanillas; Madeleine Duvic; A Deisseroth; SW Morris; WC Pugh
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():59-63.
1997: Evagelos Kostis; E Zaphiris; Lia A Moulopoulos; Meletios A Dimopoulos
Acute lobar nephronia as the presenting manifestation of hyperparathyroidism.
British journal of urology 1997;79(1):144-5.
1996: Michael J Keating; Susan O'Brien; Peter McLaughlin; Meletios A Dimopoulos; Varsha Gandhi; William Plunkett; Susan Lerner; Andrew Lamb; Elihu Estey
Clinical experience with fludarabine in hemato-oncology.
Hematology and cell therapy 1996;38 Suppl 2():S83-91.
1996: Andreas H Sarris; Rajyalakshmi Luthra; V Papadimitracopoulou; M Waasdorp; Meletios A Dimopoulos; JA McBride; Fernando Cabanillas; Madeleine Duvic; Albert Deisseroth; S W Morris; WC Pugh
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Blood 1996;88(5):1771-9.
1996: Meletios A Dimopoulos; Donna Weber; H Kantarjian; Kay Delasalle; Raymond Alexanian
HyperCVAD for VAD-resistant multiple myeloma.
American journal of hematology 1996;52(2):77-81.
1996: Meletios A Dimopoulos; Lia A Moulopoulos; C Costantinides; Charalambos Deliveliotis; Dimitrios Pantazopoulos; Constantinos Dimopoulos
Primary renal lymphoma: a clinical and radiological study.
The Journal of urology 1996;155(6):1865-7.
1996: M Mavrikakis; G Vaiopoulos; Peter Athanassiades; L Antoniades; Christos M Papamichael; Meletios A Dimopoulos
Pseudohyperphosphatemia in multiple myeloma.
American journal of hematology 1996;51(2):178-9.
1995: D Weber; Meletios A Dimopoulos; Frank A Sinicrope; Raymond Alexanian
VAD-cyclosporine therapy for VAD-resistant multiple myeloma.
Leukemia & lymphoma 1995;19(1-2):159-63.
1995: Raymond Alexanian; Meletios A Dimopoulos; Kay Delasalle; Jeane Hester; Richard Champlin
Myeloablative therapy for primary resistant multiple myeloma.
Stem cells (Dayton, Ohio) 1995;13 Suppl 2():118-21.
1995: Andreas H Sarris; Meletios A Dimopoulos; WC Pugh; Fernando Cabanillas
Primary lymphoma of the prostate: good outcome with doxorubicin-based combination chemotherapy.
The Journal of urology 1995;153(6):1852-4.
1995: N Touroutoglou; Meletios A Dimopoulos; Anas Younes; M Hess; WC Pugh; J Cox; Fernando Cabanillas; Andreas H Sarris
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1361-7.
1995: J E Bayouth; D J Macey; L P Kasi; J R Garlich; K McMillan; Meletios A Dimopoulos; R E Champlin
Pharmacokinetics, dosimetry and toxicity of holmium-166-DOTMP for bone marrow ablation in multiple myeloma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(5):730-7.
1995: Andreas H Sarris; Alejandro Majlis; Meletios A Dimopoulos; Anas Younes; F Swann; Maria A Rodriguez; Peter McLaughlin; Fernando Cabanillas
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma.
Leukemia & lymphoma 1995;17(5-6):473-7.
1995: Donna Przepiorka; R Nath; Cindy Ippoliti; RC Mehra; F Hagemeister; K Diener; Meletios A Dimopoulos; Sergio Giralt; I Khouri; B Samuels
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma.
Leukemia & lymphoma 1995;17(5-6):427-33.
1995: Charalambos Deliveliotis; Gerasimos Alivizatos; A Karayiannis; D Kontothanasis; K Makrychoritis; P Lysiotis; Meletios A Dimopoulos
The value of prostatic specific antigen in the early diagnosis of prostatic cancer: a Greek view.
British journal of urology 1995;75(5):637-41.
1995: D F Moore; Lia A Moulopoulos; Meletios A Dimopoulos
Waldenström macroglobulinemia presenting as a renal or perirenal mass: clinical and radiographic features.
Leukemia & lymphoma 1995;17(3-4):331-4.
1995: R Alexanian; Meletios A Dimopoulos
Management of multiple myeloma.
Seminars in hematology 1995;32(1):20-30.
1995: Lia A Moulopoulos; Meletios A Dimopoulos; Terry L Smith; Donna M Weber; Kay Delasalle; HI Libshitz; Raymond Alexanian
Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):251-6.
1995: Meletios A Dimopoulos; Donna Weber; Kay Delasalle; Michael Keating; Raymond Alexanian
Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(1):49-52.
1995: Donna Przepiorka; T Madden; Cindy Ippoliti; Z Estrov; Meletios A Dimopoulos
Dosing of thioTEPA for myeloablative therapy.
Cancer chemotherapy and pharmacology 1995;37(1-2):155-60.
1994: Raymond Alexanian; Meletios A Dimopoulos; Jeane Hester; Kay Delasalle; Richard Champlin
Early myeloablative therapy for multiple myeloma.
Blood 1994;84(12):4278-82.
1994: Meletios A Dimopoulos; Andrew Lamb; Donna Weber; Susan O'Brien; Elihu Estey; Kay Delasalle; E Rose; Fernando Cabanillas; Michael Keating; Raymond Alexanian
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2694-8.
1994: Donna M Weber; Meletios A Dimopoulos; D P Anandu; WC Pugh; G Steinbach
Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori.
Gastroenterology 1994;107(6):1835-8.
1994: Meletios A Dimopoulos; Antonio Palumbo; Kay Delasalle; Raymond Alexanian
Primary plasma cell leukaemia.
British journal of haematology 1994;88(4):754-9.
1994: Lia A Moulopoulos; Meletios A Dimopoulos; R Alexanian; Norman E Leeds; HI Libshitz
Multiple myeloma: MR patterns of response to treatment.
Radiology 1994;193(2):441-6.
1994: Dionisios Mitropoulos; Meletios A Dimopoulos; A Kiroudi-Voulgari; Anastasios Zervas; Constantinos Dimopoulos; C J Logothetis
Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinoma.
The Journal of urology 1994;152(4):1124-6.
1994: Meletios A Dimopoulos; S Arbuck; M Huber; Donna Weber; R Luckett; Kay Delasalle; Raymond Alexanian
Primary therapy of multiple myeloma with paclitaxel (taxol).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(8):757-9.
1994: Sergio Giralt; Charles F LeMaistre; huib vriesendorp; Borje S Andersson; Meletios A Dimopoulos; James L Gajewski; Koen van Besien; RC Mehra; Donna Przepiorka; I Khouri
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(9):1923-30.
1994: Meletios A Dimopoulos; Jeane Hester; Y Huh; Richard Champlin; Raymond Alexanian
Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma.
British journal of haematology 1994;87(4):730-4.
1994: Meletios A Dimopoulos; JC Yau; SD Huan; Sundar Jagannath; G Spitzer; J A Spinolo; G K Zagars; Charles F LeMaistre; K A Dicke; A R Zander
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation.
American journal of hematology 1994;46(2):82-6.
1994: Meletios A Dimopoulos; Donna M Weber; Jeane Hester; Kay Delasalle; Richard Champlin; Raymond Alexanian
Intensive sequential therapy for VAD-resistant multiple myeloma.
Leukemia & lymphoma 1994;13(5-6):479-84.
1994: Donna Przepiorka; Meletios A Dimopoulos; T Smith; Cindy Ippoliti; K Diener; Mario Luna; Richard E Champlin
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: risk factors for early regimen-related toxicity.
Annals of hematology 1994;68(4):183-8.
1994: Meletios A Dimopoulos; Raymond Alexanian
Waldenstrom's macroglobulinemia.
Blood 1994;83(6):1452-9.
1994: Meletios A Dimopoulos; L Finn; C J Logothetis
Pattern of failure and survival of patients with metastatic urothelial tumors relapsing after cis-platinum-based chemotherapy.
The Journal of urology 1994;151(3):598-600; discussion 600-1.
1994: Meletios A Dimopoulos; Donna M Weber; Andrew Lamb; Michael Keating; Raymond Alexanian
2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):288-9.
1994: Raymond Alexanian; Meletios A Dimopoulos
The treatment of multiple myeloma.
The New England journal of medicine 1994;330(7):484-9.
1994: Raymond Alexanian; Meletios A Dimopoulos; T Smith; Kay Delasalle; Bart Barlogie; Richard Champlin
Limited value of myeloablative therapy for late multiple myeloma.
Blood 1994;83(2):512-6.
1994: Michael J Keating; Susan O'Brien; LE Robertson; Andrew Lamb; Meletios A Dimopoulos; Peter McLaughlin; Fernando Cabanillas; V Gregoire; Y Y Li; Varsha Gandhi
The expanding role of fludarabine in hematologic malignancies.
Leukemia & lymphoma 1994;14 Suppl 2():11-6.
1994: Michael J Keating; Susan O'Brien; William Plunkett; LE Robertson; Varsha Gandhi; Elihu Estey; Meletios A Dimopoulos; Fernando Cabanillas; A Kemena; Andrew Lamb
Fludarabine phosphate: a new active agent in hematologic malignancies.
Seminars in hematology 1994;31(1):28-39.
1993: Meletios A Dimopoulos; Donna Weber; Kay Delasalle; Raymond Alexanian
Combination therapy with interferon-dexamethasone for newly diagnosed patients with multiple myeloma.
Cancer 1993;72(9):2589-92.
1993: Meletios A Dimopoulos; Raymond Alexanian; Donna Przepiorka; Jeane Hester; Borje Andersson; Sergio Giralt; RC Mehra; Koen van Besien; Kay Delasalle; C Reading
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma.
Blood 1993;82(8):2324-8.
1993: Michael J Keating; Susan O'Brien; LE Robertson; Andrew Lamb; Meletios A Dimopoulos; Peter McLaughlin; Fernando Cabanillas; V Gregoire; Li-Ying Yang; Varsha Gandhi
New initiatives with fludarabine monophosphate in hematologic malignancies.
Seminars in oncology 1993;20(5 Suppl 7):13-20.
1993: Lia A Moulopoulos; Meletios A Dimopoulos; D G Varma; J T Manning; D A Johnston; Norman E Leeds; HI Libshitz
Waldenström macroglobulinemia: MR imaging of the spine and CT of the abdomen and pelvis.
Radiology 1993;188(3):669-73.
1993: B S Davidson; Jeffrey E Lee; L G Dodd; Meletios A Dimopoulos; Douglas B Evans
Extramedullary plasmacytoma of the pancreas.
American journal of clinical oncology 1993;16(4):363-8.
1993: Lia A Moulopoulos; Meletios A Dimopoulos; Donna Weber; L Fuller; HI Libshitz; Raymond Alexanian
Magnetic resonance imaging in the staging of solitary plasmacytoma of bone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1311-5.
1993: Meletios A Dimopoulos; Fernando Cabanillas; J Jack Lee; F Swan; L Fuller; Pamela K Allen; F B Hagemeister
Prognostic role of serum beta 2-microglobulin in Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1108-11.
1993: Meletios A Dimopoulos; C J Logothetis; A Markowitz; A Sella; Robert J Amato; Jae Y Ro
Collecting duct carcinoma of the kidney.
British journal of urology 1993;71(4):388-91.
1993: Meletios A Dimopoulos; Kay Delasalle; Richard Champlin; Raymond Alexanian
Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma.
British journal of haematology 1993;83(2):240-4.
1993: Meletios A Dimopoulos; Andrew Lamb; Elihu Estey; Susan O'Brien; Kay Delasalle; Michael J Keating; Emil J Freireich; Raymond Alexanian
Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine.
Annals of internal medicine 1993;118(3):195-8.
1993: Meletios A Dimopoulos; A Moulopoulos; T Smith; Kay Delasalle; Raymond Alexanian
Risk of disease progression in asymptomatic multiple myeloma.
The American journal of medicine 1993;94(1):57-61.
1993: Meletios A Dimopoulos; Susan O'Brien; Andrew Lamb; E E Estey; Michael J Keating; Raymond Alexanian
Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.
Leukemia & lymphoma 1993;11 Suppl 2():105-8.
1992: Lia A Moulopoulos; D G Varma; Meletios A Dimopoulos; Norman E Leeds; E Edmund Kim; D A Johnston; R Alexanian; HI Libshitz
Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease.
Radiology 1992;185(3):833-40.
1992: Raymond Alexanian; Meletios A Dimopoulos; Kay Delasalle; Bart Barlogie
Primary dexamethasone treatment of multiple myeloma.
Blood 1992;80(4):887-90.
1992: Meletios A Dimopoulos; A Moulopoulos; Kay Delasalle; Raymond Alexanian
Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
Hematology/oncology clinics of North America 1992;6(2):359-69.
1992: Meletios A Dimopoulos; J Goldstein; L Fuller; Kay Delasalle; Raymond Alexanian
Curability of solitary bone plasmacytoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):587-90.
1992: Meletios A Dimopoulos; J F Fernandez; N A Samaan; P Y Holoye; Rena Vassilopoulou-Sellin
Paraneoplastic Cushing's syndrome as an adverse prognostic factor in patients who die early with small cell lung cancer.
Cancer 1992;69(1):66-71.
1991: Meletios A Dimopoulos; Bart Barlogie; Terry L Smith; Raymond Alexanian
High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma.
Annals of internal medicine 1991;115(12):931-5.
1991: Narin Voravud; Meletios A Dimopoulos; G Hortobagyi; M Ross; R Theriault
Breast cancer and second primary ovarian cancer in dermatomyositis.
Gynecologic oncology 1991;43(3):286-90.
1991: JC Yau; Meletios A Dimopoulos; SD Huan; V Spencer; S Y Woo; G Spitzer; L J Brunner; R O Wallerstein; A B Deisseroth; Borje S Andersson
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisolone.
American journal of hematology 1991;38(4):288-92.
1991: JC Yau; Meletios A Dimopoulos; SD Huan; Jeffrey J Tarrand; V Spencer; G Spitzer; C M Meneghetti; R O Wallerstein; Borje S Andersson; Charles F LeMaistre
Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation.
European journal of haematology 1991;47(5):371-6.
1991: Meletios A Dimopoulos; Robert J Amato; C J Logothetis
Predictive factors for effective salvage therapy of nonseminomatous germ cell tumors of testis.
Urology 1991;38(4):351-4.
1991: A Moulopoulos; Ronelle A DuBrow; C David; Meletios A Dimopoulos
Primary renal carcinoid: computed tomography, ultrasound, and angiographic findings.
Journal of computer assisted tomography 1991;15(2):323-5.
1991: Aris Giannopoulos; Gerasimos Alivizatos; V Kyriakou; Dionisios Mitropoulos; Meletios A Dimopoulos
Carcinosarcoma of the bladder.
British journal of urology 1991;67(1):106-7.
1990: M Likourinas; D Conidaris; Gerasimos Alivizatos; Meletios A Dimopoulos
Complete testicular feminisation syndrome in three sisters.
British journal of urology 1990;65(3):298-9.
1990: Athanasios Kostakopoulos; Charalambos Deliveliotis; E Mavromanolakis; Gerasimos Aravantinos; Meletios A Dimopoulos
Intravesical interferon alfa-2b administration in the treatment of superficial bladder tumors.
European urology 1990;18(3):201-3.
1989: Aris Giannopoulos; Dionisios Mitropoulos; P Davaris; Gerasimos Alivizatos; Meletios A Dimopoulos
Squamous cell carcinoma of the renal pelvis presenting with a loin sinus.
European urology 1989;16(6):466-8.